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Bacteria have developed multiple strategies to adapt to diverse ecological 
niches and hostile environments. One such strategy involves formation and 
maintenance of multicellular communities known as biofilms. In these microbial 
aggregates, sessile bacterial cells are encased in an extracellular matrix. It has now 
been established that c-di-GMP, a ubiquitous bacterial second messenger, is a central 
regulator of this developmental process in bacteria. It exerts its effects on 
transcriptional, translational and post-translational levels. While diguanylate cyclases 
and phosphodiesterases with conserved GGDEF and EAL (and HD-GYP) domains are 
responsible for the production and degradation of the dinucleotide, respectively, the 
receptors form a more diverse group with degenerate, catalytically inactive GGDEF-
EAL domain-containing proteins representing a major subfamily. One such protein, 
LapD from Pseudomonas fluorescens, uses an inside-out signaling mechanism to relay 
intracellular c-di-GMP concentration to control the localization of an outer-membrane 
anchored large adhesin protein LapA at the cell surface, by sequestering a periplasmic 
cysteine protease, LapG. When free, LapG cleaves the N-terminus of LapA, releasing 
it from the cell surface and ultimately leading to biofilm dispersal. 
 Based on our structure-function analysis, here we propose a mechanism for the 
c-di-GMP-mediated, regulation of periplasmic proteolysis by LapD. We first elucidate 
the molecular basis of signal recognition and relay by P. fluorescens LapD and 
identify orthologous systems in multiple other bacteria including many pathogens such 
as Legionella pneumophila. This is followed by our work on L. pneumophila LapG, 
which provides us with the first atomic models of a bacterial protease of the DUF920 
family and we are able to identify a highly conserved Ca
2+
-binding motif integral to its 
function. We then characterize the LapD-ortholog CdgS9 from L. pneumophila which 
confirms a common molecular mechanism. The crystal structure of the periplasmic 
output domain module reveals novel conformations and sheds new light on the mode 
of activation of the receptor. We finally report the structure of a complex between 
CdgS9
output
 and P. fluorescens LapG which led to the discovery of the 
pharmacologically relevant binding interface between the output domain and LapG.  
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CHAPTER 1 
 
 
Introduction 
 
 
1.1. Biofilms 
Bacteria can exist either as independent, planktonic (free-swimming) cells or as 
members of surface anchored communities known as biofilms, which are ubiquitous 
not only in nature, but also in industrial and clinical settings (1). A biofilm is a densely 
populated microbial community in which the bacterial cells are embedded in a self-
produced, extracellular matrix mainly composed of exopolysaccharides (EPS), 
proteins and nucleic acids (Fig.1.1). This matrix confers multiple advantages for the 
bacterial population. For example, it functions as a scaffold that holds the cells 
together, provides a medium for intercellular signaling as well as protects against 
environmental assaults, predators and antibiotic treatment (1, 9). In fact pathogenic, 
biofilm dwelling bacteria are often much less susceptible to antimicrobial agents than 
planktonic cells, mostly because the biofilm matrix tends to resist the penetration of 
the antibiotics into the embedded cells, rendering many commonly used antibiotics 
ineffective (2). These bacterial aggregates have also been associated with nosocomial 
infections, owing to their propensity to develop on various implants, like catheter lines 
and heart valves (3). Recently, it has been established that bacterial biofilms can also 
contribute to non-implant diseases like otitis media (inflammation of the middle ear), 
periodontitis (infection of gums and bones around the teeth) and cystic fibriosis 
(chronic lung disease in children and adolescents) (4-7). Since bacteria in biofilms are 
able to withstand antibiotic treatment, such infections and contaminations are 
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extremely difficult to eradicate. The magnitude of the problem is further amplified by 
the steady decline in the number of new FDA approved antimicrobial agents coupled 
with a rapid emergence of new, multi-drug resistant bacterial strains (8). Since 
bacterial biofilms have such a huge impact on human society, it has motivated a great 
deal of research to unravel the genetic, biochemical and physiological basis of this 
developmental process. We need to attain a fundamental understanding of the 
components and molecular mechanisms that initiate and maintain these bacterial 
communities, so that we are able to come up with effective strategies to manipulate 
these components and pathways, in order to prevent and/or disrupt bacterial biofilms. 
Biofilm development in bacteria has been proposed to occur in a series of 
highly regulated steps (9, 10). This transition in lifestyle is triggered in response to 
environmental and physiological cues like bacterial cell density, nutrient availability, 
cellular stress etc. Firstly, flagellar or pilus-mediated motility might be required for the 
cells to approach a surface to initiate reversible or transient attachment. In this phase, 
the microbial cells associate with the surface mostly through the poles of the cell, as a 
result of which this interaction is relatively weak. A subpopulation of these reversibly 
attached bacteria can then become irreversibly attached through the longitudinal axis 
of the cell (11). This shift from reversible to irreversible attachment is often brought 
about by cell surface associated adhesion factors (12). It is typically also accompanied 
by a change in the transcription profile leading to an up-regulation of genes essential 
for biofilm development and maintenance (synthesis and secretion of EPS and 
proteinaceous appendages) and down-regulation of genes responsible for motility and 
virulence (9-12). This leads to the formation of a monolayer of cells which can then 
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form micro-colonies. Over time, these micro-colonies develop into macro-colonies and 
eventually a mature biofilm is formed. Like biofilm growth, biofilm dispersal is also a 
tightly controlled process and is often set off under conditions of limited nutrient 
availability or upon accumulation of toxic waste, to release the sessile cells into the 
environment to colonize new surfaces (90, 91). For many pathogenic bacteria, biofilm 
dispersal plays an important role in the transmission of bacteria from environmental 
reservoirs to human hosts, and in the aggravation and spread of infection within a host. 
The mechanistic details of bacterial biofilm dispersal are not yet well understood but it 
is an interesting area of research that might pave the way to the development of novel 
antimicrobial agents that can either inhibit formation or promote dispersal of biofilms. 
 
 
Figure 1.1: Overview of biofilm formation (figure adapted from [61]). 
Bacteria can reversibly attach to surfaces followed by loss of motility and synthesis of 
exopolysaccharides and cellular adhesins. Mature biofilms are characterized by a 
complex architecture and collaborative behavior between functionally differentiated 
members. Finally, dispersal processes are governed by the secretion of glycolipid 
surfactants, proteases and nucleases, thereby leading to the release of highly motile 
planktonic cells, capable of colonizing new surfaces. Several of these processes are 
regulated by a bacterial second messenger, c-di-GMP (center). 
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1.2. Cyclic dimeric GMP (c-di-GMP) 
 
The bacterial second messenger cyclic dimeric (3'→5') guanylic acid (cyclic 
di-GMP or c-di-GMP) is a monocyclic RNA dinucleotide that has emerged as a central 
molecule that orchestrates the transition in bacterial life-style between the motile, 
planktonic state and the sessile, biofilm state (13, 14, 15). Besides regulating biofilm 
development, c-di-GMP has also been shown to modulate a plethora of other cellular 
and physiological processes like motility, virulence, cell cycle progression and 
differentiation (13-18). It has recently been discovered that c-di-GMP is also 
recognized by mammalian immune systems as a uniquely bacterial molecule. Thus it 
is now being considered as a promising vaccine adjuvant (19-22).  
Cyclic di-GMP was first discovered in 1987 by Benziman and colleagues, as 
an allosteric activator of Gluconacetobacter xylinus cellulose synthase (23). In the last 
25 years since its discovery, enzymes for generation (diguanylate cyclases or DGCs) 
and degradation (phosphodiesterases or PDEs) of c-di-GMP have been identified in all 
major bacterial phyla, thereby giving it the status of an universal bacterial second 
messenger. In addition to the monomeric form, c-di-GMP can also form a stable dimer 
with stacked self-intercalated guanine units and both forms have been found in crystal 
structures of c-di-GMP metabolizing and binding proteins (24-33). It is generally 
accepted that once synthesized, c-di-GMP exists as a sequestered, rather than a 
general, diffusive signal (34, 35). Quantification of cytosolic c-di-GMP levels in 
several bacterial species indicates concentrations in the micromolar range or lower. 
Considering the fact that most c-di-GMP receptors and PDEs that have been identified 
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so far have lower dissoaciation constants for the dinucleotide, it is understood that 
cellular c-di-GMP exists primarily in a protein bound form (34, 36).  
 
 
 
 
 
 
Figure 1.2: Cyclic di-GMP as a bacterial second messenger. (Figure adapted from 
[61] and [93]). 
(A) Phylogenetic distribution of prevalent RNA-based second messengers: Signal 
transduction networks that rely on the monocyclic nucleotide second messenger cAMP 
and cGMP modulate a diverse range of cellular responses in all three domains of life. 
Recent work has identified two novel RNA dinucleotides that function as intracellular 
signal amplifiers: c-di-AMP is utilized by both bacteria and archaea, while c-di-GMP 
is largely bacterial, but it has also been identified in the eukaryote Dictyostelium, a 
social amoeba.  
(B) Several distinct conformations of protein bound c-di-GMP.
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1.3. Cyclic di-GMP metabolism 
 
Cyclic di-GMP is generated from two molecules of GTP by enzymes known as 
diguanylate cyclases (DGCs) harboring the GGDEF domain (18, 33, 37, 38, 40), and 
hydrolyzed into either linear-di-GMP (pGpG) or GMP by enzymes known as 
phosphodiesterases (PDEs), with EAL (39, 40) or HD-GYP domains (40-42) (Fig. 1.4 
A-C). These c-di-GMP turnover domains are eponymous with the highly conserved, 
signature amino acid motifs of their active sites, and are often found in association 
with a wide variety of signal input domains implying that a broad range of 
environmental and cellular inputs can be integrated into the c-di-GMP signaling 
network. The GGDEF domain also often contains a c-di-GMP-binding site (I-site) 
distal to the active site, which is involved in an allosteric negative feedback regulation 
(product-inhibition). Genomic and bioinformatics analyses have shown that these c-di-
GMP metabolizing domains can exist in nature either as stand-alone protein domains 
or in tandem as a part of the same polypeptide chain. The co-existence of two domains 
with opposing enzymatic activities in the same protein however represents an 
“enzymatic conundrum”, raising interesting questions about their mode of regulation 
and final enzymatic output (43, 44).  
Theoretically, three possibilities exist that might explain this “enzymatic 
conundrum”. One scenario is where both domains are catalytically active, but they are 
differentially regulated by environmental or cellular signals such that only one activity 
is prevalent at any given point. Examples of such bifunctional enzymes include 
proteins BphG1 from Rhodobacter sphaeroides, with a PAS-GAF-PHY-GGDEF-EAL 
module (45), MSDGC-1 from Mycobacterium smegmatis, with a GAF-GGDEF-EAL 
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domain architecture (92) and Lpl0329 from Legionella pneumophila, which contains a 
REC-GGDEF-EAL module (46). A second scenario is possible where one of the two 
tandem domains is catalytically inactive (47, 48) and plays an allosteric role in 
modulating the output of the enzymatically active domain, either by binding (but not 
processing) the substrate, e.g. GTP-binding by inactive GGDEF domains (CC3396 
protein from Caulobacter crescentus; 47) and c-di-GMP binding by inactive EAL 
domains (32, 49, 50), or by mediating protein-protein or protein-RNA interactions. 
Finally, a third scenario is possible where both the domains have completely lost their 
enzymatically activity but can function as receptors of c-di-GMP. The transmembrane 
protein LapD from P. fluorescens is an example of this type of tandem GGDEF-EAL 
domain proteins (51, 52).   
GGDEF and EAL/HD-GYP domains are found to be among the most abundant 
protein domains encoded in bacterial genomes, which interestingly concurs with the 
ability of bacteria to survive and flourish in diverse ecological niches. The surprisingly 
large number of predicted c-di-GMP signaling proteins in some genomes (there are 43 
in one of our study organisms, P. fluorescens Pf0-1) raises the possibility that c-di-
GMP signaling networks are extraordinarily complex. Recent studies provide strong 
evidence that c-di-GMP signaling proteins (DGCs or PDEs) can impact distinct 
outputs through differential subcellular localization (49, 53-55). Other studies have 
shown that c-di-GMP signaling proteins in the same pathway physically interact with 
one another or their targets (56, 57). These data, combined with the well-established 
role for oligomerization in regulating DGC and PDE activities (37, 58, 59), points to 
protein-protein interactions and multi-protein complexes as a likely means for 
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compartmentalizing specific c-di-GMP signals. Understanding how c-di-GMP 
receptors participate in generation of biological outputs regulated by this nucleotide is 
essential to understanding a critical component of the bacterial lifestyle, that is, the 
transition between motile and sessile states. 
 
 
 
 
Figure 1.3: Cyclic di-GMP signaling module. (Figure adapted from [61]). 
(A) Cyclic di-GMP signal generation, degradation and recognition: While protein 
domains catalyzing c-di-GMP synthesis and hydrolysis have been fairly well 
characterized, effectors of the dinucleotide are only beginning to emerge. 
(B) Effectors or receptors of c-di-GMP: Modules and proteins for c-di-GMP sensing 
are diverse. While several bacterial effectors have been studied extensively, only a few 
well-validated targets on host cells have been discovered till date. Others await further 
characterization. 
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1.4. Bacterial c-di-GMP receptors 
Unlike c-di-GMP turnover enzymes which are readily identifiable based on 
primary sequence information, c-di-GMP effector components are much more diverse 
and cannot be represented by any one single domain or c-di-GMP binding site. At 
present, although our knowledge about c-di-GMP receptors and their downstream 
targets is rather limited, this situation is rapidly changing and new classes of c-di-GMP 
effectors are beginning to emerge (as summarized in recent reviews [60-62]).  
One of the most well characterized classes of c-di-GMP receptors comprises 
proteins containing PilZ domains (e.g. PA2960 from P. aeruginosa, YcgR from 
Escherichia coli [63], BcsA from G. xylinus [64], DgrA protein from C. crescentus 
[65], and PlzC and PlzD from Vibrio cholerae [66]). The PilZ domain can either occur 
as a separate protein domain or be present downstream to an EAL or GGDEF-EAL 
composite unit. Interestingly, the PilZ domain proteins can bind c-di-GMP either as a 
closed monomer (67) or as a self-intercalated dimer (30, 64) and can also adopt 
different oligomeric states from monomeric to tetrameric (30, 68, 69), implying 
potentially different modes of downstream signal propagation. 
Enzymatically inactive GGDEF domains with their allosteric c-di-GMP-
binding I-sites (RxxD motif) form a second class of c-di-GMP receptors (24, 70). 
Some examples of this category of receptors include the response regulator PopA from 
C. crescentus, the hybrid histidine kinase SgmT from Myxococcus xanthus and PelD, 
which regulates c-di-GMP-dependent polysaccharide biosynthesis in P. aeruginosa 
(71, 72). Likewise, catalytically incompetent EAL domains that have retained their 
ability to bind the dinucleotide can also function as c-di-GMP receptors, e.g. FimX, a 
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protein that governs twitching motility in P. aeruginosa (32), YkuI from Bacillus 
subtilis and LapD, an inner-membrane localized protein that modulates biofilm 
development in P. fluorescens in response to exogenous inorganic phosphate 
availability (73).  
Bacterial transcriptional regulators that modulate gene expression upon binding 
cytosolic c-di-GMP constitute another interesting class of c-di-GMP receptors. 
Enhancer-binding protein FleQ from P. aeruginosa with an AAA
+/ATPase σ54-
interaction domain, the matrix production and motility regulation protein VpsT from 
V. cholerae, which harbors a non-canonical receiver domain, and the CRP/FNR-type 
transcriptional activators from Xanthomonas and Burkholderia (57, 74–76), are a few 
examples of this category. 
The discovery of c-di-GMP-specific riboswitches as a novel class of c-di-GMP 
receptors by Breaker and colleagues has further diversified the gamut of physiological 
outputs regulated by this prokaryotic dinucleotide signaling molecule. Riboswitches 
are RNA aptamers that undergo changes in their secondary structure conformation 
upon binding small molecule ligands thereby modulating the transcription and/or 
translation of downstream genes (77-81). Two different types of these short c-di-
GMP-binding RNA molecules are currently known, c-di-GMP-I and c-di-GMP-II, the 
former being more prevalent in the bacterial kingdom.
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1.5. Mammalian c-di-GMP receptors 
Eukaryotic immune systems have previously been shown to recognize c-di-
GMP as an exclusive bacterial molecule, but the molecular basis of 
immunostimulation by c-di-GMP has become clear with the identification of the 
transmembrane protein STING as a direct sensor of the dinucleotide signal (82, 83). 
STING binds c-di-GMP in vitro with a dissociation constant (kd) of 5 µM and triggers 
generation of type I interferons by signaling through the TANK binding kinase 1 
(TBK1) and the interferon regulatory transcription factor 3 (IRF3). Recently, a second 
mammalian c-di-GMP sensing protein has been identified, the DEAD-box helicase 
DDX41 (84) which appears to have a slightly higher affinity for dinucleotide binding. 
However, it is still not completely understood as to how this bacterial intracellular 
second messenger makes its way into the cytosol of macrophages or whether its 
concentration ever reaches micromolar levels. 
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Figure 1.4: Structural organization cyclic di-GMP-related proteins. (Figure 
modified from [44]). 
The upper row shows enzymes of c-di-GMP metabolism, and the lower row shows 
two types of c-di-GMP-binding proteins.  
(A) GGDEF domain of PleD from C. crescentus with the bound substrate analog 
GTPαS. Bound Mg2+ ions are shown as violet spheres. Active site glutamate is shown 
in yellow (86) (PDB entry 2V0N). 
(B) EAL domain of Tbd1265 with bound c-di-GMP. Bound Mg
2+
 ions are shown as 
violet spheres. Active site glutamate is shown in yellow (65) (PDB entry 3N3T).  
(C) HD-GYP domain of Bd1817. Bound Fe atoms are shown as violet spheres. 
HDxxP motif is shown in yellow (129) (PDB entry 3TM8). 
(D) C-di-GMP binding site of the PilZ domain of PA4608 (82) (PDB entry 2L74). 
(F) C-di-GMP bound to the stimulator of interferon genes STING (74) (PDB entry 
4EMT).
A B C
D E
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1.6. Protein targets of interest 
 
Arguably, the most well understood role of a c-di-GMP-mediated signaling 
cascade in bacteria is in regulation of biofilm development. Cyclic di-GMP has been 
shown to impact biofilm growth in multiple layers including control at the 
transcriptional, translational and post-translational levels. There is evidence that c-di-
GMP can regulate the various extracellular matrix components that contribute to 
biofilm structure, including biosynthesis and secretion of exopolysaccharides, 
proteinaceous fimbriae, adhesive pili and extracellular DNA (85).  
Using gram-negative species of bacteria such as Pseudomonas fluorescens, 
Pseudomonas aeruginosa, Legionella pneumophila and Vibrio cholerae, we attempted 
to unravel the structural and mechanistic aspects of c-di-GMP mediated control of 
biofilm growth, maintenance and dispersal and its possible role in disease 
pathogenesis. Based on recent reports as well as personal communication with our 
collaborators, we chose several putative and known genes as targets of our studies. My 
efforts were primarily directed towards understanding the molecular basis of c-di-
GMP mediated inside-out signaling and its role in regulating periplasmic proteolysis, a 
project I pursued in close collaboration with Prof. George O’Toole’s group at 
Dartmouth.  
Over the past decade the O’Toole lab has explored the mechanism whereby P. 
fluorescens forms a biofilm and studied how a key environmental nutrient, inorganic 
phosphate, regulates the formation of biofilms by this soil pseudomonad. We next 
wanted to use a combination of genetic, biochemical and structural studies to elucidate 
the mechanistic basis of this process. 
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Figure 1.5: Lap operon and LapD/LapG functional cycle.  
Current model summarizing how Pi level controls biofilm formation by P. fluorescens. 
Right: Under conditions of low Pi, activation of the PhoR kinase leads to 
phosphorylation of PhoB. PhoB~P dimer binds to the Pho Box sequence upstream of 
the rapA gene, activating its transcription (86). The RapA protein cleaves c-di-GMP to 
form pGpG through its PDE activity, depleting cellular c-di-GMP pools, which in turn 
leads to the dissociation of the nucleotide from the c-di-GMP effector LapD. This 
signal promotes the egress of LapA to the culture supernatant. The loss of LapA 
requires the functional LapG periplasmic protease. In low Pi conditions, when c-di-
GMP is low, the periplasmic domain of LapD does not bind to LapG, and LapG is free 
to cleave the N-terminus of LapA. Cells cannot maintain stable surface attachments in 
low Pi due to loss of LapA. This causes biofilm dispersal. 
Left: Under high Pi conditions RapA is not expressed, and c-di-GMP accumulates in 
the cell. LapD binds c-di-GMP and sends a signal across the inner membrane 
promoting the maintenance of LapA on the cell surface. LapD promotes LapA-
mediated cell-surface adherence because it binds LapG and sequesters LapG from 
processing the N-terminus of LapA. Cells with full-length LapA on their cell-surface 
can form irreversible attachments to the substratum and form a biofilm (87). 
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One pathway c-di-GMP regulates biofilm development is through the cell 
attachment machinery of P. fluorescens, with the Lap operon at its center. This operon 
constitutes a set of genes which are absolutely essential for biofilm formation by P. 
fluorescence in response to nutrient availability. It consists of the large secreted 
protein LapA, an ABC transporter (LapEBC) for its delivery to the cell surface, a 
periplasmic protease LapG and the c-di-GMP receptor LapD (11, 51, 87-89). LapA, a 
large adhesin (predicted protein of ~520 kDa), is localized to the cell surface and plays 
a critical role in the establishment of biofilms by P. fluorescens, in particular, during 
an early step called “irreversible attachment”, whereby bacterial cells attach 
themselves to the surface via their long axis. Secretion of this adhesin requires the 
LapEBC, an ATP binding cassette type transporter. The key environmental nutrient, 
inorganic phosphate (Pi) regulates biofilm formation via the well characterized Pst-
PhoRB regulatory system. Pst-PhoRB controls biofilm formation in response to 
phosphate via the transcriptional control of RapA, a c-di-GMP-specific PDE, which 
when expressed, depletes intracellular levels of this signaling molecule (88, 89) (Fig. 
1.5). Reduced cytosolic levels of c-di-GMP in turn results in the cleavage and release 
of LapA from the cell surface (88).  
LapD is an inner membrane localized c-di-GMP-binding protein that controls 
biofilm formation by controlling localization of LapA on the cell surface in response 
to changing pools of c-di-GMP in the cytoplasm. LapD contains degenerate and 
enzymatically inactive GGDEF (DGC) and EAL (c-di-GMP-specific PDE) domains, 
and is the first protein shown to bind c-di-GMP through a degenerate EAL domain 
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(51). LapD mediates LapA localization in response to Pi-mediated changes in cytosolic 
c-di-GMP levels by regulating the activity of a periplasmic protease LapG (Fig 1.5). 
LapG, which is encoded by a gene adjacent to lapD, is a periplasmically-
localized cysteine protease required to proteolyze LapA between residues of a 
conserved Ala-Ala motif (residues 108-109), resulting in the release of LapA from the 
cell surface (87). Thus LapD utilizes a novel ‘inside-out’ signaling mechanism: 
binding c-di-GMP in the cytoplasm and communicating this signal to the periplasm 
via LapD’s HAMP and periplasmic domains to connect environmental modulation of 
intracellular c-di-GMP levels by Pi to regulation of LapA localization, and thus surface 
commitment by P. fluorescens (51). 
In the following chapters we will present detailed structural and functional 
analyses of the transmembrane c-di-GMP sensing protein LapD, the periplasmic 
cysteine protease LapG and the LapG-LapD
output 
complex. In addition, we will propose 
an array of future experiments to help further characterize c-di-GMP mediated 
pathways that regulate social behavior in bacteria. 
In the first chapter, I contributed to our first attempts to elucidate the structure 
and regulation of LapD. In particular, as part of this work, I determined the first crystal 
structure of P. fluorescens LapD’s periplasmic output domain. Through sequence 
conservation mapping onto the three-dimensional structure, I identified an invariable 
residue at the distal tip of the output domain that is critical for its interaction with 
LapG. I also established an in vitro binding assay to monitor LapG’s interaction with 
the periplasmic output domain of LapD, and could show that the aforementioned 
conserved residue was crucial for the interaction. In the second chapter, I describe the 
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first structural characterization of a bacterial transglutaminase like cysteine protease 
(BTLCP). My work on L. pneumophila LapG has provided the first atomic models of 
a protease belonging to this family. I have also been able to identify a strictly 
conserved, calcium-binding motif in LapG that is crucial for its proteolysis activity. 
Ca
2+
-binding by LapG has been validated and quantified in solution using isothermal 
titration calorimetry. I have also shown that L. pneumophila LapG can cleave the 
corresponding substrate from P. fluorescens, thereby suggesting a common 
mechanism of substrate recognition and proteolytic cleavage. In the third chapter of 
my thesis, I have described the structural analysis of the periplasmic output domain of 
the LapD ortholog from L. pneumophila as well as its complex with P. fluorescens 
LapG. On the basis of these structures, I have successfully identified the binding 
interface between these two proteins as well as the conformational changes induced by 
ligand binding. The final chapter summarizes my work and describes future goals.
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CHAPTER 2 
Structural basis for c-di-GMP-mediated inside-out signaling controlling 
periplasmic proteolysis* 
 
2.1. Abstract 
The bacterial second messenger c-di-GMP has emerged as a central regulator 
of biofilm formation. Increased cellular c-di-GMP levels lead to stable cell attachment, 
which in Pseudomonas fluorescens requires the widely conserved, transmembrane 
receptor LapD. C-di-GMP binding to its degenerate phosphodiesterase domain is 
communicated via a HAMP relay to the periplasmic domain, triggering sequestration 
of the protease LapG, thus preventing cleavage of the surface adhesin LapA. Here, we 
elucidate the molecular mechanism of autoinhibition and activation of LapD. In the 
absence of c-di-GMP, the intracellular module assumes an inactive conformation that 
is incompetent for dinucleotide binding. C-di-GMP binding to the phosphodiesterase 
domain disrupts the inactive state, forming a dimer interface between adjacent 
phosphodiesterase domains via interactions conserved in c-di-GMP-degrading 
enzymes. Efficient mechanical coupling of the conformational changes across the 
membrane is realized through an extensively domain-swapped, unique periplasmic 
fold. Our analyses identified a conserved system for the regulation of periplasmic 
proteases in a wide variety of bacteria, including many free-living and pathogenic 
species. 
 
*Reproduced with permission from [Marcos V.A.S. Navarro, Peter D. Newell, Petya 
V. Krasteva, Debashree Chatterjee, George A. O’Toole, and Holger Sondermann, 
(2011). PLos Biology, 9(2):e1000588]. doi:10.1371/journal.pbio.1000588. 
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2.2. Introduction 
Bacterial biofilms arise from planktonic microbial cells that attach to surfaces 
and form sessile multicellular communities, a process relevant to their survival in 
hostile habitats and for bacterial pathogenesis (1). Recent work has identified biofilm 
formation as a multiphase process with strict temporal and spatial regulation, often 
accompanied by adaptational strategies such as phenotypic variation, development of 
antibiotic resistance, and virulence gene expression (2, 3). On the cellular level, 
functional differentiation events including changes in motility, cell adhesion, and 
secretion are among the many processes driving bacterial biofilm formation. Such a 
plethora of physiological responses inevitably poses the question of how regulation is 
achieved, and a nucleotide unique to bacteria, cyclic dimeric GMP (c-di-GMP), has 
emerged as a key signaling molecule in this process (4, 5). 
Cyclic di-GMP is a monocyclic RNA dinucleotide that functions as an 
intracellular second messenger exerting control at the transcriptional, translational, and 
posttranslational levels (6). It is generated from two GTP molecules by GGDEF 
domain–containing diguanylate cyclases, and degraded by phosphodiesterases 
containing either EAL or HD-GYP protein domains (7–10). The majority of cellular c-
di-GMP appears to be bound to protein, eliciting localized, rather than diffusive 
signals (5). To date, only a few c-di-GMP receptors have been identified. Protein 
domains involved in c-di-GMP signal recognition include PilZ domains (12, 13), a 
non-canonical receiver domain in VpsT of Vibrio cholerae (14), the AAA σ54 
interaction domain–containing transcription factor FleQ of Pseudomonas aeruginosa 
(15), and the cyclic nucleotide monophosphate–binding domain in Clp of 
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Xanthomonas campestris (16). In other cases, c-di-GMP turnover domains can also 
serve as sensors for the dinucleotide. For example, in GGDEF domain–containing 
proteins, an RxxD motif can serve as a c-di-GMP-binding inhibitory site either to 
regulate the activity of active enzymes (e.g., PleD of Caulobacter crescentus and 
WspR of P. aeruginosa) (17, 18) or to mediate protein–protein interactions in 
degenerate homologs (e.g., PelD of P. aeruginosa and CdgG of V. cholerae) (19, 20). 
Bacterial proteins that mediate c-di-GMP turnover and signal transduction are 
often composed of multiple domains, allowing for a variety of regulatory inputs, 
signaling events, and/or physiological responses (21). For example, a large number of 
these proteins contain both GGDEF and EAL domains in the same polypeptide chain. 
These proteins fall into three main categories based on their catalytic activity: tandem 
domain–containing proteins with both diguanylate cyclase and phosphodiesterase 
activity; proteins with only one active domain, in which the degenerate, inactive 
domain exhibits a regulatory function; and proteins in which both domains are 
degenerate and likely to work as c-di-GMP receptors (22, 23). Despite the frequent 
occurrence of this signaling module in bacterial genomes, structural and mechanistic 
insight regarding their function and regulation is sparse. 
The transmembrane protein LapD belongs to the last group, containing 
degenerate GGDEF and EAL domains that lack catalytic activity, but capable of c-di-
GMP binding via its divergent phosphodiesterase domain (24). LapD is required for 
stable cell attachment and biofilm formation in P. fluorescens and P. putida (25–27). It 
responds to changes in cellular c-di-GMP levels modulated by the availability of 
inorganic phosphate, an essential nutrient that is limiting in many ecosystems (24, 28). 
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Under phosphate starvation conditions, the expression of the phosphodiesterase RapA 
is upregulated, reducing cellular c-di-GMP levels and cell attachment. Increased 
phosphate availability yields an inactive Pho regulon, reduced RapA expression, and, 
as a consequence, a rise in cellular c-di-GMP concentration. As c-di-GMP levels 
change LapD switches between two states: the dinucleotide-unbound “off” state that 
retards stable biofilm formation by facilitating the secretion of the cell surface adhesin 
LapA, and the c-di-GMP-bound “on” state that supports cell adhesion by preventing 
the release of LapA from the outer membrane (24, 26). Binding of c-di-GMP to the 
LapD EAL domain is relayed to the periplasmic output domain through an inside-out 
signaling mechanism that utilizes a juxtamembrane HAMP domain, a relay module 
often found in bacterial transmembrane receptors (24). 
Recent work by Newell et al. (29) reveals the complete c-di-GMP signaling 
circuit by which LapD controls cell attachment in response to phosphate availability. 
For wild-type LapD, c-di-GMP binding appears to induce a conformational change, 
which activates the receptor. As a consequence, the affinity of the periplasmic domain 
for the cysteine protease LapG increases, limiting its access to LapA. Perturbations in 
the HAMP domain by deletion of some key elements yield a constitutively active 
receptor, independent of dinucleotide binding. However, it has remained unclear as to 
what prevents LapD from adopting an active conformation and how dinucleotide 
binding translates into an output signal.  
Here, we present three crystal structures of LapD from P. fluorescens that 
provide models for the c-di-GMP-unbound cytoplasmic domain lacking only the 
HAMP domain, a c-di-GMP-bound EAL domain dimer, and the periplasmic domain. 
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Together these structures span almost the entire receptor and elucidate molecular 
mechanisms that regulate LapD function. The crystal structure of the cytoplasmic 
module containing the GGDEF–EAL tandem domains reveals the presence of an 
autoinhibitory motif formed by a helical extension of the HAMP domain. In this 
inactive state, the GGDEF domain restricts dinucleotide access to the EAL domain 
module. The crystal structure of dimeric, c-di-GMP-bound EAL domains provides 
insight into the conformational changes resulting from dinucleotide binding. Based on 
the crystal structure of the periplasmic output domain of LapD, we identify 
functionally important residues and propose a model for the regulation of LapD 
activity in inside-out signal transduction. Finally, our structural studies highlight many 
conserved features that allow us to identify similar signaling systems in a variety of 
bacterial strains including common pathogens such as V. cholerae and Legionella 
pneumophila. 
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2.3. Results and Discussion 
Inactive State of the Intracellular Module of LapD 
In order to elucidate the molecular mechanism that regulates LapD function, 
we determined the crystal structure of the intracellular module of P. fluorescens LapD, 
comprising a HAMP–GGDEF domain linker segment and the degenerate GGDEF–
EAL domain module (LapD
dual
; residues 220–648) (Fig. 2.1). Based on secondary 
structure predictions, the linker forms a continuation of the second HAMP domain 
helix (Fig. 2.2). We will refer to this motif as the signaling helix (S helix). The 
structure of LapD
dual
 (space group P32, one molecule in the asymmetric unit) was 
solved by single-wavelength anomalous dispersion phasing using selenomethione-
substituted protein crystals (Table 2.1). We also obtained a second crystal form 
involving different crystal packing contacts (space group I23, one molecule in the 
asymmetric unit), yet the overall structure of LapD
dual
 in the two crystals is identical 
(root mean square deviation [rmsd] of 0.9 Å over all atoms; Fig. 2.3A and 2.3C). In 
both cases, the biologically significant unit was predicted to be a monomer (33). 
LapD
dual
 adopts a compact, bilobal conformation (Fig. 2.1A). The GGDEF 
domain, comprising the N-terminal lobe, caps the dinucleotide-binding pocket of the 
EAL domain, which forms the C-terminal lobe of the tandem domain structure. The 
EAL domain buttresses the N-terminal S helix via predominantly hydrophobic 
interactions, burying 1,170 Å
2
 (Fig. 2.1). The binding groove on the EAL domain, 
which accommodates the S helix, consists of the helix α6 and an adjacent loop. The 
latter has been identified as a conserved motif in catalytically active EAL domain–
containing phosphodiesterases, in which it is involved in dimerization and catalysis 
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(34, 40). In LapD, the consensus sequence of the loop determined for active 
phosphodiesterases is not conserved (40). This loop was referred to as loop 6 in 
SadR/RocR (40) and β5-α5 loop in the light-regulated phosphodiesterase BlrP1 (34). 
We will refer to this motif as the switch loop of LapD. 
In addition to the S helix–EAL domain interaction, the GGDEF domain 
contacts the dinucleotide-binding surface of the EAL domain at multiple points, 
forming a loosely packed interface that buries 1,620 Å
2
 of surface area (Fig. 2.1A, 
2.4A, and 2.4B). One such contact, the salt bridge between an arginine residue (R
450
) 
and a glutamate residue (E
262
), forms a particularly close interaction (Fig. 2.4A). R
450
 
is located just downstream of the signature EAL motif (KVL in LapD) at the center of 
the c-di-GMP-binding site. E
262
 is presented by a loop of the GGDEF domain. While 
E
262
 directly occupies the dinucleotide-binding site, the loop itself is located at its 
periphery, partially blocking access of c-di-GMP to the EAL domain (Fig. 2.4B). 
Although the conformation of apo-LapD observed in the crystal structure is 
incompatible with c-di-GMP binding, the binding site is not completely occluded (Fig. 
2.4B), and there may be a sufficient proportion of accessible EAL domains in solution 
to respond to increasing c-di-GMP concentrations, competing with the inhibitory 
interactions. In addition, there may be cooperative effects within the dimeric, full-
length receptor that are not apparent from the structures of the isolated domains. 
The loop that connects the S helix to the GGDEF domain adopts a 
conformation that is identical to the linkage between active diguanylate cyclase 
domains and their regulatory domains (Fig. 2.4C). The conformation is stabilized by a 
salt bridge between two strictly conserved residues that are located at the beginning of 
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the connecting loop and just upstream of the signature GGDEF motif (
318
RGGEF
322
 in 
LapD), respectively: D
239
 in the loop and R
316
 in the GGDEF domain of LapD, D
174
 
and R
249
 in WspR, and D
292
 and R
366
 in PleD (17, 18, 38, 41). This interaction likely 
constrains the loop conformation, restricting the overall rotational freedom of the 
GGDEF domain relative to its associated regulatory module, the S helix in the case of 
LapD and the response receiver domain in the case of PleD and WspR. 
In summary, the structural analysis of the cytoplasmic domain of LapD reveals 
that in the absence of c-di-GMP, the protein resides in a conformation incompatible 
with dinucleotide binding, with the GGDEF domain restricting access of c-di-GMP to 
the EAL domain. Dinucleotide binding would be accompanied by a major 
conformational change disrupting the conformation observed in the crystal structure.
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Figure 2.1: Autoinhibited structure of the cytoplasmic domain of LapD (Data 
courtesy of Marcos V.A.S. Navarro).  
(A) Crystal structure of apo-LapD
dual
. The domain organization of LapD from P. 
fluorescens Pf0-1 is shown. The degenerate sequence of the GGDEF and EAL 
signature motifs are indicated. The crystal structure of the LapD
dual
 (residues 220–648) 
is shown as ribbon presentation and colored according to the domain diagrams (upper 
panel). The S helix forms an extension of the second HAMP domain helix. The switch 
loop is sensitive to the nucleotide-binding state of the EAL domain and is involved in 
dimerization and catalysis in active phosphodiesterases. Two views, separated by a 
180° rotation, are shown.  
(B) The S helix–EAL domain interface. A close-up view of the S helix–EAL domain 
interface is shown, with residues involved in direct, pairwise interactions shown as 
sticks. Two views, separated by a 260° rotation, are shown. Helix α6 and the switch  
loop form a surface buttressing the S helix.
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Table 2.1: X-ray data collection and refinement statistics 
. 
 
LapD
EAL
•c-di-
GMP (1) 
LapD
EAL
•c-di-
GMP (2) 
LapD
output
 
(Se-Met) 
LapD
dual
 (1) LapD
dual
 (2) 
LapD
dual
 (2) 
(Se-Met) 
Data Collection 
X-ray source CHESS, A1 CHESS, A1 CHESS, A1 CHESS, F2 CHESS, A1 CHESS, A1 
Wavelength (Å) 0.9771 0.9771 0.9771 0.9793 0.9771 0.9771 
Space group C2221 P6522 P212121 I23 P32 P32 
Unit cell       
a, b, c  (Å) 
41.4, 204.8, 
142.4 
141.5, 141.5, 
111.2 
41.5, 71.4, 
110.4 
154.8, 154.8, 
154.8 
52.1, 52.1, 
146.3 
52.4, 52.4, 
146.5 
α, β, γ (°) 90, 90, 90 90, 90, 120 90, 90, 90 90, 90, 90 90, 90, 120 90, 90, 120 
Resolution (Å)
a 50-2.5 (2.59-
2.5) 
50-2.5 (2.59-
2.5) 
50-1.8 (1.83-
1.77) 
50-3.1 (3.29-
3.1) 
30-2.0 
(2.07-2.0) 
50-2.5 (2.59-
2.5) 
No. of reflections       
Total 
172,322 
(12,035) 
568,367 
(34,934) 
433,383 
(26,900) 
123,220 
(18,906) 
188,981 
(17,162) 
105,992 
(8,859) 
Unique 20,943 (1,973) 23,191 (2,211) 
32,517 
(3,092) 
11,246 
(1,775) 
29,997 
(2,959) 
31,174 
(3,055) 
Completeness 
(%) 
99.1 (94.4) 99.7 (97.4) 99.5 (96.7) 98.9 (98.7) 99.7 (98.8) 99.8 (98.4) 
Redundancy 8.2 (6.1) 24.5 (15.8) 13.3 (8.7) 10.9 (10.7) 6.3 (5.8) 3.4 (2.9) 
I/σ(I) 19.8 (3.5) 34.4 (3.7) 30.2 (4.1) 29.4 (3.4) 42.6 (3.3) 24.0 (3.2) 
Rmeas (%) 8.7 (33.9) 7.5 (43.6) 6.5 (37.3) 7.8 (78.5) 4.4 (47.7) 4.7 (28.2) 
Refinement 
Rwork / Rfree (%) 
18.1 / 24.5 19.6 / 22.5 19.4 / 22.5 23.4 / 28.4 18.1 / 22.2  
rms deviations       
Bond length (Å) 0.009 0.008 0.006 0.011 0.011  
Bond angles (°) 1.271 1.239 0.994 1.405 1.233  
No. of atoms       
Protein 3866 2001 1979 3315 3315  
c-di-GMP 92 46 0 0 0  
Water 115 125 304 0 180  
Ave. B-factors 
(Å
2
) 
      
Protein 37.2 54.2 32.6 83.8 54.0  
cyclic di-GMP 28.4 46.9 -- -- --  
Water 34.3 50.6 43.3 -- 51.1  
Ramachandram 
(%) 
      
Favored 93.2 93.2 94.3 88.5 93.6  
Allowed 6.8 6.8 5.7 11.2 5.8  
Generously 
allowed 
0.0 0.0 0.0 0.0 0.3  
Disallowed 0.0 0.0 0.0 0.3 0.3  
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Figure 2.2: Sequence alignment of LapD homologs.  
A sequence alignment of LapD homologs from various species was generated with 
ClustalW2 (60) and formatted with ESPript (61). Key residues discussed in the 
manuscript are marked with closed green arrows. The degenerate GGDEF and EAL 
signature motifs (RGGEF and KVL, respectively) are marked with yellow bars. 
Secondary structure elements are shown based on the crystallographic data and 
secondary structure predictions for the transmembrane and HAMP domains. The 
following sequences were used to generate the alignment: Pseudomonas 
fluorescens Pf0-1 (LapD, YP_345864), Pseudomonas putida KT2440 (NP_742334), 
Pseudomonas aeruginosa PA01 (NP_250124), Pectobacterium carotovorum subsp. 
brasiliensis PBR1692 (ZP_03826388), Citrobacter sp. ATCC 29220 (ZP_06355256), 
Polaromonas sp. JS666 (YP_547171), Rhodoferax ferrireducens T118 (YP_524995), 
Dechloromonas aromatica RCB (YP_286553), Cellvibrio japonicus Ueda107 
(YP_001981887), Legionella pneumophila str. Lens (YP_126219), Geobacter sp. M18 
(ZP_05313414), Vibrio alginolyticus 12G01 (ZP_01258281), Vibrio 
parahaemolyticus  AQ3810 (ZP_01990882), Vibrio harveyi HY01 
(ZP_01986262), Vibrio shilonii AK1 (ZP_01866121), Vibrio cholerae 1587 
(ZP_01950486), Vibrio fischeri ES114 (YP_207124) and Vibrio angustum S14 
(ZP_01233947).
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Figure 2.3: Crystal forms of LapD
dual
 and LapD
EAL•c-di-GMP.  
(A) LapD
dual
: Two independent crystal forms were obtained for LapD
dual
. The resulting 
structures were superimposed on the EAL domain and shown as protein backbone 
traces. 
(B) C-di-GMP-bound LapD
EAL
: Two independent crystal forms were obtained for 
LapD
EAL
. Both crystal lattices show the same dimeric assembly of EAL domains. 
Dimers were superimposed on one EAL domain and shown as protein backbone 
traces.  
(C) Stereo views: Stereo views of the structural comparisons shown in (A) and (B) are 
shown. In this view, the EAL domains of LapD
dual
 and LapD
EAL•c-di-GMP are shown 
in a similar orientation. 
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Figure 2.4: GGDEF–EAL domain interactions and S helix–GGDEF domain 
linker conformation observed in apo-LapD
dual
.  
(A) GGDEF–EAL domain interaction: Close-up views are shown for regions of direct 
contact between the GGDEF and EAL domains in the autoinhibited structure of 
LapD
dual
. The GGDEF and EAL domains are colored in green and orange, 
respectively. The S helix is colored in blue.  
(B) Nucleotide-binding pocket in apo-LapD
dual
: A close-up view of the c-di-GMP-
binding pocket of LapD is shown (right panel). C-di-GMP is shown as a stick 
presentation after superimposing the crystal structure of LapD
EAL•c-di-GMP onto the 
EAL domain of apo-LapD
dual
. The interacting residue pair R
450
/E
262
 in LapD is 
incompatible with c-di-GMP binding. The left panels show surface presentations of 
apo-LapD
dual
. The middle panel shows accessibility of the c-di-GMP-binding site, with 
c-di-GMP taken from LapD
EAL•c-di-GMP after superimposition.  
(C) S helix–GGDEF connector: The S helix and the GGDEF domain are connected via 
a short loop that forms a tight turn. The loop conformation is conserved in other 
GGDEF domain–containing proteins, and is stabilized by the interaction between two 
residues D
239
 and R
316
, which are strictly conserved in many GGDEF domain–
containing proteins (17),(18),(38),(41). The arginine residue is directly preceding the 
GGDEF domain signature motif (GGDEF or GGEEF in active cyclases; RGGEF in 
LapD); the aspartate residue is located at the N-terminus of the loop. Its strict sequence 
and conformational conservation suggest a functional importance of the connector 
loop, likely restricting the conformational freedom between adjacent domains.
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Crystal Structure of LapD
EAL
·c-di-GMP 
The crystal structure of LapD
EAL
 bound to c-di-GMP (residues 399–648; 
LapD
EAL
·c-di-GMP; Fig. 2.5) was solved by molecular replacement (Table 2.1). We 
obtained crystals in two independent conditions, yielding two different crystal forms 
(space group C2221, two molecules per asymmetric unit; space group P6522, one 
molecule per asymmetric unit; Fig. 2.3B and 2.3C).  
Cyclic-di-GMP binding did not alter the overall conformation of the EAL 
domain observed in the apo-LapD
dual
 structure (rmsd of 0.6 Å over all atoms) (Fig. 
2.5), consistent with the lack of major conformational changes upon dinucleotide 
binding to the EAL domains of YkuI, TDB1265, and FimX (35–37). Minor changes in 
the dinucleotide-binding pocket are confined to four c-di-GMP coordinating residues 
that adopt alternate side chain rotamer conformations (Fig. 2.5A). 
The most notable conformational change in LapD
EAL
 upon c-di-GMP binding 
occurs in the switch loop (Fig. 2.5B). Dinucleotide binding and the absence of the S 
helix in the isolated EAL domain allow the loop to restructure, resulting in the 
switching of the conserved phenylalanine residue F
566
 (Fig. 2.5B). In apo-LapD
dual
, the 
side chain of F
566
 faces inward and is located at the center of the S helix–binding 
interface (Figure 2.1B). In contrast, the switch loop adopts a conformation in the c-di-
GMP-bound structure positioning F
566
 so that it can participate in homodimerization 
(Fig. 2.5B and 2.6). Whether this change is due to the flexibility of the loop, adjusting 
its conformation to accommodate the S helix–bound and dimeric states, or depends on 
dinucleotide binding awaits further structural analysis.  The symmetric LapD
EAL
 
domain dimer is reminiscent of the oligomeric state in active EAL domain–containing 
phosphodiesterases, such as in P. aeruginosa SadR/RocR, Bacillus subtilis YkuI, 
Thiobacillus denitrificans TDB1265, and the BLUF domain–regulated photoreceptor 
BlrP1 from Klebsiella pneumonia (34, 35, 37, 40). Most importantly, dimerization of 
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the c-di-GMP-bound EAL domains is incompatible with the conformation observed in 
the crystals of apo-LapD
dual
 (Fig. 2.6C). The surface occupied by the S helix overlaps 
significantly with the homodimerization interface, which indicates that dinucleotide-
induced conformational changes will include the displacement of the GGDEF domain 
and the S helix. 
 
 
 
Figure 2.5: Comparison between the dinucleotide-free and c-di-GMP-bound EAL 
domain of LapD (Data courtesy of Petya V. Krasteva). 
(A) Crystal structure of LapD
EAL•c-di-GMP: The c-di-GMP-bound structure of 
LapD
EAL
 (gray) was superimposed onto the dinucleotide-free structure of LapD
dual
 
(orange residues). The S helix and GGDEF domain were omitted for clarity. A close-
up view of the dinucleotide-binding pocket is shown, with residues involved in c-di-
GMP binding presented as sticks. The (|Fo| - |Fc|) electron density map is shown as 
calculated from a model prior to inclusion of dinucleotide and is contoured at 3.5σ.  
(B) Conformational change of the switch loop: C-di-GMP binding and absence of the 
S helix allow the switch loop to adopt an alternative conformation (orange: apo-
LapD
dual
; gray: LapD
EAL•c-di-GMP). As a consequence, the side chain of F566, a 
residue involved in both S helix interaction in LapD
dual
 and dimerization of LapD
EAL
, 
changes position. 
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Figure 2.6: Dimerization of c-di-GMP-bound LapD
EAL
. 
(A) EAL domain dimerization: In both crystal forms obtained for LapD
EAL•c-di-GMP 
we observe symmetric dimerization between protomers involving helix α6 and the 
switch loop. Dimerization buries 1,350 Å
2
 of surface area. 
(B) Dimer interface: A close-up view (left panel) and cartoon diagram (right panel) of 
the dimer interface is shown.  
(C) Comparison of apo-LapD
dual
 and LapD
EAL•c-di-GMP: The EAL domain from the 
crystal structure of dinucleotide-free LapD
dual
 was superimposed on one c-di-GMP-
bound EAL domain from dimeric LapD
EAL
. LapD
dual
 is colored as shown in Fig. 2.1. 
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Analysis of the Regulatory Mechanisms of LapD in Solution 
Based on the crystallographic data, a simple model would suggest that LapD is 
subject to an autoinhibition mechanism. In contrast to other c-di-GMP receptors with 
known structures where the dinucleotide-binding site is freely accessible in the apo-
state (Fig. 2.8), intramolecular interactions restrict dinucleotide access to the EAL 
domain in LapD. Cyclic-di-GMP binding would disrupt these interactions, resulting in 
a change in conformation of the receptor. Alternatively, mutations in the regulatory 
features predicted to destabilize the interaction should relieve the autoinhibition and 
alter the shape and activity of the receptor. 
To test this model, structure-guided mutations were introduced into LapD to 
assess the functional relevance of the autoinhibitory conformation and EAL domain 
dimerization (Fig. 2.7). Site-directed mutations were introduced into the S-helix that 
was predicted to weaken its interaction with the EAL domain without affecting EAL 
domain dimerization propensity (F
222
A, F
222
E, S
229
D, E
230
A, or L
232
E; Fig. 2.1B). 
Another set of mutations targeted the GGDEF–EAL domain interface, focusing on 
changes in the GGDEF domain that would not interfere with EAL domain function 
(M
252
E, E
262
A, or E
333
A; Fig. 2.4A). Finally, A
602
 was targeted for mutation as it was 
identified as a residue at the center of the EAL domain dimerization interface (Fig. 
2.6B). The structure of apo-LapD
dual
 showed A
602
 at the periphery of the S helix–EAL 
domain interaction, suggesting that perturbations at this site may maintain the 
autoinhibited state (Fig. 2.1B).  
Mutations were introduced into LapD
dual
, the EAL domain, and the full-length 
receptor. It is important to note that LapD is a dimeric receptor via its HAMP and 
49 
 
output domains, and therefore EAL domain dimerization (and dinucleotide binding) 
represents a conformational change within the receptor, rather than a change in its 
oligomeric state. The comparative analyses described below reveal the basic properties 
of the cytoplasmic module of LapD, especially the correlation between c-di-GMP 
binding and dimerization (Fig. 2.7 and 2.8). However, the specific interaction energies 
will likely be enhanced in the context of the full-length receptor compared to those of 
the isolated domains. Cell-based assays elucidate the functional relevance of these 
properties in intact LapD (Fig. 2.10 and 2.11). 
We next analyzed the oligomerization state of LapD
dual
 protein variants in 
solution, using static multi-angle light scattering (MALS) (Fig. 2.9). This method 
provides the population-averaged absolute molecular weight and hence quaternary 
state of proteins eluting from a gel filtration column. The technique measures the 
intensity of scattered laser light from a particle at multiple angles, which is 
proportional to the product of the molecular weight and the concentration of the 
particle, permitting rapid and facile comparison of oligomeric equilibria across a series 
of mutants (42). 
The wild-type LapD
dual
 protein elutes in a single peak from the size exclusion 
column with a molecular weight of 43.5 kDa, indicating a monomeric state in solution 
(Fig. 2.9A, left column). Incubation of the protein with c-di-GMP shifted the peak 
elution volume and increased the molecular weight slightly to 54.5 kDa. While being 
monomeric in the absence of dinucleotide, both the S helix–EAL and the GGDEF–
EAL interface mutants (S
229
D and E
262
A, respectively) showed more distinct shifts in 
molecular weight towards dimeric species upon c-di-GMP binding (77.5 kDa and 71.4 
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kDa, respectively; Fig. 2.9A, left column). As predicted on the basis of the structural 
analysis, LapD
dual
 variants containing a glutamate substitution in place of A
602
 (A
602
E 
and S
229
D/A
602
E) are monomeric in solution, independent of the presence of 
dinucleotide and unaffected by the additional mutation S
229
D. 
In general, the intermediate molecular weights and non-Gaussian peak shapes 
observed for wild-type LapD
dual
 and the mutants S
229
D and E
262
A, predicted to be less 
inhibited, incubated with c-di-GMP prior to gel filtration, may indicate a fast exchange 
between monomeric and dimeric species relative to the data acquisition time and/or 
instability of the complex. To further investigate this phenomenon, we conducted 
concentration-dependent experiments by subjecting LapD
dual
 to light scattering 
measurements at concentrations between 20 and 320 mM with or without incubation 
in c-di-GMP. All samples eluted as single peaks from the gel filtration column and 
showed no signs of unspecific protein aggregation. Protein concentration 
determination across the peak volume indicated that samples were diluted consistently, 
15-fold during the chromatography. All LapD
dual
 variants were monomeric in the 
absence of c-di-GMP across the entire concentration range (Fig. 2.9B). LapD
dual
 
proteins with a mutation at the dimerization interface (A
602
E or S
229
D/A
602
E) were 
insensitive to c-di-GMP addition and remained monomeric. Wild-type LapD
dual
 
showed signs of oligomerization only at the highest concentrations tested. In contrast, 
the molecular weight of LapD
dual
 variants with single-point mutations S
229
D or E
262
A, 
predicted to disrupt autoinhibitory features, increased in a concentration-dependent 
manner in the presence of c-di-GMP, indicative of dimerization of the isolated 
cytoplasmic domain in solution. 
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In summary, LapD appears to be autoinhibited for efficient dinucleotide 
binding by structural features involving the S helix and occupancy of the c-di-GMP-
binding site by the GGDEF domain. Based on the observation that the A
602
E mutation 
located in the EAL domain homodimer interface and outside of the c-di-GMP-binding 
site, renders the protein monomeric and reduces dinucleotide binding, we propose that 
dimerization and c-di-GMP binding are interdependent events in LapD
dual
 and 
LapD
EAL
.  
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Figure 2.7: c-di-GMP binding of LapD
dual
 in solution.  
Mutant categories: Structure-guided, site-directed mutants in LapD are illustrated. 
Mutations in brackets were used in experiments shown in Fig. 2.10 and 2.11. 
Structure-based predictions regarding the c-di-GMP binding and c-di-GMP-dependent  
dimerization propensities are indicated.
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Figure 2.8: Structural comparion of LapD with other c-di-GMP receptors.  
(A) LapD: The monomoric apo-LapD
dual
 structure is shown as a surface presentation 
(top). The middle panel shows the c-di-GMP-bound EAL domain of LapD in two 
orthogonal views. The dinucleotide-binding site is colored in red. The conformation of 
c-di-GMP is similar to that observed in other EAL domains such as FimX, YkuI, and 
BlrP1 (bottom panel) (17),(18),(34)–(38).  
(B) VpsT (PDB IDs 3kln and 3klo): The transcription factor VpsT from V. 
cholerae exists in a monomer–dimer equilibrium. An apo-VpsT monomer is shown as 
a surface presentation (top panel). The dimeric species is stabilized by c-di-GMP 
binding to the base of the regulatory receiver domain (middle panel) (14). Two 
molecules of c-di-GMP form an intercalated dimer, similar to the binding mode 
observed for the inhibitory site binding in active diguanylate cyclases (17), (38). The 
dinucleotide binding site is shown in red.  
(C) PilZ domains (PDB IDs 1yln, 2rde, 3yg, and 3kyf): The PliZ domain–containing 
protein PlzD/VCA0042 forms homodimers via its YcgR-N* domain. The PilZ 
domains form separate lobes of the protein. PilZ domain–containing proteins have 
been shown to bind either one or two mutually intercalated molecules of c-di-GMP 
 (54). The dinucleotide binding site is shown in red.
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Figure 2.9: Quaternary state of LapD
dual
 in solution.  
(A) Oligomerization of LapD
dual
 in solution: SEC-coupled MALS analysis of wild-
type and mutant LapD
dual
 in the presence and absence of c-di-GMP is shown. The 
signal from the 90° scattering detector is shown in color, and the signal from the 
refractive index detector is shown as a dashed line. Average molecular weights are 
plotted in black against the right y-axis as calculated every second across the protein 
elution peak. Theoretical molecular weights corresponding to those of a monomer and 
a dimer are indicated as horizontal dashed gray lines. Injected protein and dinucleotide 
concentrations were 250 mM and 500 mM, respectively. In the right panel, the mobile 
phase contained c-di-GMP (50 mM). Earlier elution times may indicate a more 
elongated conformation of certain mutants in solution (for example, of the mutant 
S
229
D compared to wild-type or the E
262
A variant in the absence of c-di-GMP), which 
is probably due to a displacement of the GGDEF domain from the EAL domain.  
(B) Concentration-dependent dimerization of LapD
dual
: SEC-MALS experiments were 
carried out with samples of increasing LapD
dual
 concentration. The samples of highest 
concentration correspond to data shown in (A). The data point shown as a star 
represents data obtained for samples run in a mobile phase that contained c-di-GMP. 
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Effect of Structure-Based Mutations in LapD on Biofilm Formation 
Stable biofilms of P. fluorescens require LapD expression and the presence of 
c-di-GMP (24). To examine the contribution of inter-domain interactions to LapD’s 
function in vivo, full-length LapD variants were assessed for their ability to promote 
biofilm formation in a ΔlapD mutant strain (Fig. 2.10). We observed a range of 
phenotypes, from a slight reduction in biofilm formation relative to the wild-type, to 
strong hyper-adherent phenotypes comparable to that observed when ΔLapD is 
constitutively activated by mutations in the HAMP domain (24) (Fig. 2.10 and 2.11). 
The mutation that we predict to disrupt the S helix–EAL interface in the autoinhibited 
conformation, S
229D, caused an ‘‘activated’’ phenotype. Similar results were obtained 
with the mutant F
222
E, whereas a less disruptive alanine substitution was tolerated at 
this position. 
In the apo-LapD
dual
 structure, the E
262
 residue is positioned such that it would 
occlude binding of c-di-GMP to the EAL domain (Fig. 2.4B). Consistent with this, the 
E
262
A mutation results in an increase in biofilm formation relative to the wild-type 
allele (Fig. 2.10A). Yet, the E
262
A mutant phenotype is not as extreme as that 
exhibited in the case of the S
229
D mutation, despite comparable increases in c-di-GMP 
binding and dimerization by these proteins in vitro (Fig. 2.9). This suggests that the 
E
262
A mutant is still subject to autoinhibition in vivo, albeit with higher sensitivity for 
c-di-GMP than the wild-type protein. Structurally, this may be explained by removal 
of the side chain that directly occupies the c-di-GMP-binding site without disturbing 
the S helix–EAL domain interaction. Other mutations showed intermediate (L232E and 
M
252
E) or no significant changes (F
222
A, E
230
A, and E
333
A) in phenotype, roughly 
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corresponding to their surface exposure in the autoinhibited state structure (Fig. 2.1B, 
2.4A, and 2.10A). The A
602
E mutation, which disrupts the dimerization interface of the 
EAL domain and reduces steady state c-di-GMP binding in vitro (Fig. 2.9), led to a 
small but significant decrease in biofilm formation relative to the wild-type allele (Fig. 
2.10). The observation that the A
602
E mutant showed a minor loss of function in vivo, 
distinct from the more pronounced loss of function observed with mutants in the 
dinucleotide binding pocket (24), argues that dimerization increases the stability of the 
dinucleotide bound state rather than being required for c-di-GMP binding per se. 
While this modest reduction in function in vivo seemed incongruous with the severe 
defect in dimerization and binding exhibited by the dual-domain and EAL domain 
construct in vitro, we further tested its significance by introducing the A
602
E mutation 
into activated alleles of LapD, S
229
D, and F
222
E. The reduction in biofilm formation in 
the double mutants was significant, corroborating that EAL domain dimerization plays 
a role in LapD function in vivo (Fig. 2.10B). The single mutants were also tested for 
their response to phosphate starvation, a physiological input for LapD-mediated 
signaling that leads to a reduction of cellular c-di-GMP concentration (24, 28). At low 
c-di-GMP concentration, wild-type LapD activity is downregulated, which results in 
the release of the adhesin LapA from the cell surface and thus a reduction in biofilm 
formation (Fig. 2.11A, top) (24). Mutations in the S helix–EAL domain interface 
(F
222
E and S
229
D) failed to respond to phosphate starvation efficiently, showing little 
to no reduction in biofilm formation (Fig. 2.11A). The effect was comparable to a 
deletion mutant described previously, in which a helical segment of the HAMP 
domain was removed, yielding a constitutively active, deregulated receptor (Fig. 
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2.11A) (24). In contrast, mutation of the residue in the GGDEF domain that occupies 
the c-di-GMP binding site (E
262
A) showed an intermediate response to phosphate 
starvation, suggesting that mutant receptor function is still controlled by c-di-GMP, 
albeit not as effectively as in wild-type LapD (Fig. 2.11A). Similar to the trends 
observed in the static biofilm assay (Fig. 2.10A), other mutations in LapD showed 
more subtle effects in the phosphate starvation experiments (Fig. 2.11B). 
Collectively, these results suggest that the S helix–EAL domain interface 
stabilizes the off state. The interaction is the dominant autoinhibitory feature 
responsible for positioning the GGDEF domain to occlude the c-di-GMP-binding 
pocket and therefore ensure appropriate control of LapD activation in vivo. In addition, 
EAL domain dimerization via a conserved mode of interaction is likely to contribute to 
the efficiency of the signaling system by stabilizing the activated conformation, 
although it appears to be a secondary component of the activation mechanism. 
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Figure 2.10: Phenotypic analyses of lapD mutants (Data courtesy of Peter D. 
Newell). 
(A) Biofilm phenotypes: Biofilm formation of ΔlapD cells expressing full-length, 
wild-type LapD, LapD point mutants, or the insert-less expression vector was 
assessed. Crystal violet-stained biofilms (top) and their quantification (bottom) are 
shown. Data are means 6 SD of eight replicates. Protein levels were determined by 
Western blotting using a primary antibody that recognizes His6 epitope at the C-
terminus of LapD. The asterisk marks a residue at the center of the EAL domain 
dimerization interface.  
(B) Biofilm phenotypes of double mutants: The analysis was carried out as described 
in (A). Data are means 6 SD of eight replicates. 
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Figure 2.11: Phosphate-regulated c-di-GMP signaling via LapD (Data courtesy of 
Peter D. Newell). 
(A) Phosphate-regulated c-di-GMP signaling: Phosphate (Pi) starvation leads to the 
expression of the active phosphodiesterase RapA and a reduction in cellular c-di-GMP 
concentration (24). LapD mutants were tested for their response to limiting phosphate 
concentration. Biofilm formation was monitored over 90 min after physiological 
activation of the Pho system in low phosphate medium, and compared to biofilm 
formation in phosphate-rich medium. The mutant DH1 contains an activating deletion 
in the HAMP domain and has been described previously (24). Data are means ± SD of 
eight replicates.  
(B) Mutants showing intermediate responses: The analysis was carried out as  
described in (A). Data are means ± SD of eight replicates.
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Crystal Structure of LapD’s Periplasmic Output Domain 
In order to shed light on how changes in the cytosolic domain are sensed in the 
periplasm, we determined the structure of the entire output domain (residues 22–151; 
Fig. 2.1A). Crystals grown with selenomethionine-derivatized protein diffracted X-
rays to a maximum resolution of 1.8 Å (Table 2.1). The structure was solved by 
single-wavelength anomalous dispersion phasing (SAD). The final model consists of 
two molecules per asymmetric unit spanning residues 23–150 (Fig. 2.12A and 2.13A). 
The periplasmic output domain of LapD forms an extensively interwoven, 
domain-swapped dimer sharing 3,429 Å
2
 interfacial surface area between the 
protomers (1/3 of LapD’s output domain molecular surface) (Fig. 2.12 and 2.13B). 
The dimer adopts an overall V-shaped conformation. Each arm of the fold consists of 
two -helices and two β-strands contributed by one of the two protomers, 
complemented by two β -strands flanked by helical segments from the other. The N- 
and C-terminal helices of LapD’s output domain presumably connect directly to the 
transmembrane helices and the HAMP domains. The two half sites are linked via a 
long connecting segment that crosses over at the center of the dimer. The two 
protomers superimpose well except for a subtle rigid body rotation around the linker 
(Fig. 2.13A). 
A DALI (distance-matrix alignment) search comparing LapD’s output domain 
to proteins in the RSCB Protein Data Bank (PDB) revealed structural similarity of its 
domain-swapped arms to the periplasmic domain of the sensor histidine kinase CitA 
(Z-score = 5.4, rmsd of 2.5 Å) (43–45). The periplasmic modules of CitA and related 
proteins show some homology to PAS domains and have been classified as PDC 
(PhoQ-DcuS-CitA) protein domains (46, 47). Such domains occur in many other 
bacterial transmembrane proteins, but unlike LapD’s output domain, they are found to 
form a variety of regular, non-swapped dimers (44, 47, 48). 
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A sequence alignment of 18 sequences was constructed, including LapD 
homologs from other Pseudomonas strains and extending to more distantly related 
sequences from other bacterial genera (Fig. 2.2; Table 2.2). Mapping sequence 
conservation onto the accessible molecular surface revealed a few potentially 
important motifs (Fig. 2.12C and 2.14). The PxWF and LW segments (residues 103–
106 and 144–145 of LapD, respectively) form a continuous surface at the bottom of 
the dimer. While the LW segment is part of the surface that accommodates the long N-
terminal helix of the adjacent protomer, the PxWF is likely to interact with the inner 
membrane. The other striking feature is a strictly conserved loop connecting the 
strands β3 and β4 formed by the conserved GWxQ motif (residues 124–127 of LapD). 
W
125
 forms the most distal point of the periplasmic domain located at the center of the 
loop, and its side chain is in an outward-facing rotamer conformation (Fig. 2.12C).  
Given its strict conservation and peculiar conformation, we targeted W
125
 in a 
site-directed mutagenesis study, replacing its side chain non-conservatively with a 
glutamate residue. The mutant output domain expressed and purified indistinguishably 
from the wild-type protein but had distinct functional properties. In a purified system 
using hexahistidine (His6)–tagged LapG, a periplasmic cysteine protease that binds to 
LapD’s output domain in a c-di-GMP-dependent manner (29), we could efficiently 
pull down the untagged wild-type output domain (Fig. 2.12D). This result indicates 
that in the absence of the transmembrane and cytoplasmic domains, the output domain 
adopts a LapG-binding-competent state. In contrast, the output domain mutant W
125
E 
failed to interact with LapG in this assay. Consistent with these results, a full-length 
allele harboring the W
125
E mutation failed to restore LapD-dependent biofilm 
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formation in a ΔlapD genetic background (Fig. 2.12E). The periplasmic loss-of-
function mutation is also dominant over the highly activating S
229
D mutation when 
introduced in the same allele, underlining the functional importance of W
125
 in   
transmitting cytosolic signaling events to the periplasm.
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Figure 2.12: Structure–function analysis of the output domain of LapD.  
(A) Crystal structure of LapD
output
: The crystal structure of the periplasmic output 
domain of LapD (residues 22–151) is shown as a ribbon presentation, with the two 
protomer chains colored in pink and gray, respectively. The relative position of the 
inner cell membrane (gray bar) and connection to the flanking transmembrane (TM) 
helices are indicated. Two orthogonal views are shown.  
(B) Topology diagram: The diagram illustrates the domain-swapped structure of the 
dimeric output domain.  
(C) Surface conservation: Based on an alignment of 18 sequences of LapD homologs, 
the sequence conservation was mapped onto the accessible surface of the output 
domain. One protomer is shown as a surface presentation while the other is shown as a 
ribbon presentation. Conserved motifs and individual residues are highlighted.  
(D) LapD
output–LapG complex formation: Purified His6-tagged LapG (His6-LapG) was 
bound to NiNTA, and incubated in the absence or presence of untagged, wild-type 
LapD
output
, or a LapD
output
 mutant in which W
125
 has been replaced with a glutamate. 
The Coomassie-stained gel shows eluates of NiNTA-bound proteins.  
(E) Biofilm phenotypes and LapD stability: Biofilm formation of ΔlapD cells 
expressing full-length, wild-type LapD, LapD point mutants, or the insert-less 
expression vector was assessed. Protein levels are shown by Western blotting for the  
His6 epitope at the C-terminus of LapD.
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Figure 2.13: Structural analysis of LapD
output
 and potential mechanisms for 
higher-order oligomerization of LapD.  
(A) Comparison between LapD
output
 protomers: The periplasmic output domain of 
LapD crystallized with two molecules in the asymmetric unit. The protomers were 
superimposed on the first two helices of the fold, revealing a minor, rigid-body 
rotation of one half of the molecule relative to the other half between the two 
protomers. The rotation occurs at the connecting loop between β2 and α3 that forms 
the crossing-over point in the domain-swapped dimer.  
(B) LapD
output
 crystal packing: Domain-swapped dimers of the output domain interact 
predominantly via two interfaces in the crystal lattices. One involves bottom-to-bottom 
interaction between LapD
output
 dimers via a conserved, hydrophobic patch coinciding 
with the putative membrane-interaction surface. The other interface involves 
hydrophobic interactions between the arms of the V-shaped output domain dimers.  
(C) Potential higher-order oligomerization based on the structure of LapD
output
: Crystal 
lattice contacts reveal a potential mode for higher-order assemblies of LapD. The 
close-up view (right panel) shows the hydrophobic contacts between output domain 
dimers.  
(D) Potential higher-order oligomerization based on the structure of LapD
EAL•c-di-
GMP: In the C2221 crystal lattice, EAL domains form higher-order lattices that may 
highlight a mode for receptor oligomerization in the membrane. 
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Figure 2.14: Surface conservation and hydrophobicity of LapD
output
.  
(A) Surface conservation: Based on an alignment of 18 sequences of LapD homologs 
(Fig. 2.2), the sequence conservation was mapped onto the solvent-accessible surface 
of the output domain. One protomer is shown as a surface presentation while the other 
is shown as a ribbon presentation. Conserved motifs and individual residues are 
highlighted. Two views, separated by a 180° rotation, are shown.  
(B) Hydrophobicity mapped onto the molecular surface of LapD
output
: The surface is 
colored according to the hydrophobicity of accessible residues. Hydrophobic residues 
are shown in green; polar and charged residues are in gray and pink, respectively. 
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Table 2.2: Strains and plasmids 
. 
Strain or plasmid Genotype or Description Reference 
Escherichia coli   
S17-1(λpir) thi pro hsdR- hsdM+ ΔrecA RP4-2::TcMu-Km::Tn7 
(Simon et 
al., 1983) 
Saccharomyces cerevisiae   
InvSc1 uracil auxotroph Invitrogen 
Pseudomonas fluorescens   
ΔlapD unmarked deletion of the lapD gene 
(Newell et 
al., 2009) 
   
Plasmids   
pMQ72 2μ URA3; ori & rep pR01600; colE1, aac1 PBAD araC 
(Shanks et 
al., 2006) 
pLapD LapD with C-terminal 6 His tag expressed from PBAD 
(Newell et 
al., 2009) 
pLapD ΔH1 
pLapD with 7 amino acid deletion in first helix of HAMP 
domain 
(Newell et 
al., 2009) 
pLapD W
125
E pLapD point mutation in the indicated codon or codons This study 
pLapD W
125
E,S
229
D pLapD point mutation in the indicated codon or codons This study 
pLapD F
222
A pLapD point mutation in the indicated codon or codons This study 
pLapD F
222
E pLapD point mutation in the indicated codon or codons This study 
pLapD S
229
D pLapD point mutation in the indicated codon or codons This study 
pLapD E
230
A pLapD point mutation in the indicated codon or codons This study 
pLapD L
232
E pLapD point mutation in the indicated codon or codons This study 
pLapD M
252
E pLapD point mutation in the indicated codon or codons This study 
pLapD E
262
A pLapD point mutation in the indicated codon or codons This study 
pLapD E
333
A pLapD point mutation in the indicated codon or codons This study 
pLapD A
602
E pLapD point mutation in the indicated codon or codons This study 
pLapD F
222
E,A
602
E pLapD point mutation in the indicated codon or codons This study 
pLapD S
229
D,A
602
E pLapD point mutation in the indicated codon or codons This study 
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Structure-Based Model for the Regulation of Periplasmic Proteases in Bacteria 
Our structural analyses of LapD revealed an autoinhibited conformation of the 
cytosolic domains in the absence of c-di-GMP, a dimeric state of c-di-GMP-bound 
EAL domains in the active state, and a domain-swapped dimer of the periplasmic 
output domain that is competent for LapG binding. The HAMP domain was modeled 
based on available structural information for this relay module, with the S helix 
forming a continuous extension of the HAMP domain’s second helix (49, 50). In 
conjunction with the biochemical and genetic analyses described in an accompanying 
manuscript, we propose the following model for the activation of LapD and its 
mechanism of inside-out signaling across the inner bacterial membrane (Fig. 2.15). 
The S helix and GGDEF domain function as a physical lock, gating access of c-di-
GMP to the EAL domain. In this conformation, LapD’s output domain is held in a 
LapG-binding-incompetent state, and hence LapG gains access to and cleaves LapA, 
releasing this critical biofilm adhesin from the cell surface. An increase in the cellular 
c-di-GMP level, concomitant with a sampling of a c-di-GMP-binding-competent 
conformation of LapD, will outcompete the inhibitory interactions in the cytoplasmic 
domains, likely accompanied by a large conformational change allowing EAL domain 
dimerization. Coupling between dimerization and c-di-GMP binding may further 
contribute to the efficiency of the activation switch, by preventing reversal to the 
autoinhibited state. Many mutations in the cytoplasmic module including the HAMP 
domain lead to aberrant, constitutive activation of LapD (Fig. 2.10 and 2.11) (24). 
These data suggest that intrinsic autoinhibitory interactions are indeed necessary to 
prevent the system from adopting a constitutively active conformation.  
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Based on the primary sequence and secondary structure predictions, the HAMP 
domain is directly linked to the GGDEF–EAL domain module via the S helix. HAMP 
domains occur in a large number of predominantly transmembrane sensor proteins that 
transmit signals from the environment across the cell membrane to elicit an 
intracellular response (outside-in signaling) (21). Rotation of the helices in HAMP 
dimers has been described as the main mechanism for signal transmission (49). It is 
conceivable that the EAL domain–S helix interaction stabilizes the off state, and that 
the release of the EAL domain from the S helix will allow the receptor to relax. The 
disengagement may trigger a rotation in the HAMP domain in a similar fashion to in 
other HAMP domains (49, 50), yielding a conformational change in the output domain 
and allowing the periplasmic domain of LapD to sequester LapG. 
What is the relevance of the unusual fold of LapD’s output domain? Unlike 
CitA and related sensor proteins, which bind small molecules in the periplasm and 
relay this information to the inside of the cell, LapD sequesters a periplasmic protein 
upon receiving a cytosolic signal. We speculate that a domain-swapped fold would 
respond more efficiently and precisely in coupling conformational changes in the 
cytosolic domains across the membrane than canonical dimeric periplasmic domains. 
One may consider the periplasmic domain of LapD as a single domain given the 
extensive sharing of structural elements and a negligible monomer–dimer transition. 
Given the functional importance and the particular position of W
125
, we hypothesize 
that the output domain may act as a molecular ruler, with the tryptophan residues 
forming the tips of the caliper. Varying the angle between the arms of the V-shaped 
fold upon c-di-GMP-triggered HAMP domain rotation could form the basis for 
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modulating binding of LapG in the periplasm, assuming that both tryptophan residues 
of the dimeric, periplasmic fold interact with LapG (monomers or dimers). 
Although competent for specific LapG binding, the isolated LapD output 
domain failed to compete for LapG sequestration with the full-length c-di-GMP-bound 
receptor (P. D. N., unpublished data). It is likely that the intracellular and 
transmembrane domains facilitate the formation of a stable, high-affinity state. In 
addition, removal of the domain from its native context may alter its conformation. 
The observation that the isolated output domain can bind LapG is consistent with a 
model in which the dinucleotide-free, intracellular domains hold the receptor in an 
autoinhibited conformation that relaxes into a LapG-binding state upon activation. 
Consequently, deletion of the regulatory domains would allow for the output domain 
to adopt the active, LapG-binding conformation. In addition, potential higher-order 
oligomerization of LapD into lattices may contribute to sequestering LapG over larger 
membrane surfaces and to the fine-tuning of the signaling system. Two crystal 
structures described here, of the output domain and the c-di-GMP-bound EAL domain, 
show some potentially relevant higher-order interactions (Fig. 2.13C and 2.13D). 
Further experiments will be required to determine the oligomeric state of full-length 
LapD in the absence and presence of c-di-GMP. 
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Figure 2.15: Structure-based model for LapD inhibition and activation. 
(A) Structural model of full-length LapD: We derived models for the autoinhibited and 
activated, c-di-GMP-bound state of LapD based on the crystal structures described 
here. Only the c-di-GMP-bound receptor is capable of LapG binding in the periplasm. 
The HAMP domains were modeled based on sequence alignments and available 
structural information (49-50).  
(B) Model for LapD-mediated control of biofilm formation: The cartoon presents the 
current model for biofilm formation controlled by the c-di-GMP receptor LapD, based  
on our structural and functional analyses, previous results (24–26, 29).
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Conservation of Signaling Systems Involving LapD Homologs  
Based on sequence conservation, LapD homologs in other Pseudomonas 
strains, including P. putida and P. aeruginosa, are likely to function in a similar 
fashion (Fig. 2.2; Table 2.2) (24, 27). While LapD and LapG from P. aeruginosa 
(PA1433 and PA1434, respectively) show a high degree of sequence conservation and 
functionally rescue deletions in these genes in P. fluorescens, no biofilm phenotype 
has been associated with this signaling system in their native strain (23), consistent 
with the absence of an obvious LapA homolog in this species. In contrast, we 
identified similar effector systems and targets in more distant genera including 
Legionella and various Vibrio strains. In all these bacteria, lapD and lapG homologs 
with conserved, functionally important residues exist within the same operon (Fig. 2.2; 
Table 2.2). LapD from V. cholerae El Tor represents a special case since its EAL 
domain is encoded by a second gene, separated from the transmembrane receptor 
containing the output, HAMP, and GGDEF domains. While the relevance of this 
finding requires further investigation, these genes have been found upregulated in 
rugose strains of V. cholerae, associated with increased biofilm formation (51). 
The bioinformatic analysis also detected the presence of associated ABC 
transporters in genomes encoding LapD homologs, as in the case of P. fluorescens. 
Putative substrates of the cysteine protease LapG may fall into one of two categories. 
The large adhesin LapA as a LapG substrate, involved in biofilm formation and 
stability in P. fluorescens (29). Based on the cleavage site sequence, other LapA 
homologs were identified in a variety of strains. In addition, we predict that LapG 
homologs may have different substrates in systems for which no clear LapA-type 
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proteins could be identified. Regions with homology to the LapG-cleavage site of 
LapA have been identified in RTX-like bacterial toxins, and for the majority of such 
candidate substrates, these proteins are encoded in close genetic proximity to lapD and 
lapG homologs. 
The GGDEF–EAL domain–containing proteins described here are degenerate 
with respect to their active sites, lack catalytic activity, and function as c-di-GMP 
receptors. A similar system has been previously described in Escherichia coli. Unlike 
LapD, the transmembrane HAMP–GGDEF–EAL domain–containing protein CsrD 
regulates degradation of regulatory RNAs, but we speculate that the cytosolic module 
may be autoregulated in a similar fashion (52). Other proteins containing the tandem 
domain module with a higher degree of conservation at the putative enzyme active 
sites exist in association with a HAMP domain in some bacterial genomes (e.g., V. 
cholerae). The mechanism described for LapD may also be applicable to these 
systems, in which the HAMP domain and S helix could be regulatory features to 
control the phosphodiesterase and/or diguanylate cyclase activity in the outside-in 
signaling mechanism, thus leading to changes in cellular c-di-GMP levels. 
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2.4. Conclusions 
Here, we elucidated the molecular mechanism underlying the function and 
regulation of P. fluorescens LapD, a transmembrane receptor essential for biofilm 
formation in this strain. Similar receptors are conserved in many bacteria where they 
control a LapG-type, periplasmic protease. LapD is autoinhibited with regard to c-di-
GMP binding by interactions of the EAL domain with the S helix and the GGDEF 
domain. Receptor activation requires the concurrent release of the EAL domain from 
these interactions and the binding of c-di-GMP, which triggers a conformational 
change in the output domain from an incompetent to a competent state with regard to 
LapG binding (29). Mutations in the regulatory features that weaken the autoinhibitory 
interactions render LapD constitutively active even under phosphate starvation (low c-
di-GMP levels; Fig. 2.11). This is in contrast to other c-di-GMP receptors with known 
structure, such as PilZ domain–containing proteins (53, 54), VpsT (14), and the 
GGDEF–EAL domain–containing protein FimX (36). In PlzD, dinucleotide binding 
introduces a conformational change that changes the relative orientation of its two 
domains (53). In FimX, the EAL domains form the distal tips of an elongated, dimeric 
protein (36). Cyclic-di-GMP binding to the isolated EAL domain or the full-length 
protein is indistinguishable, and no major conformational change has been observed 
for FimX upon dinucleotide binding (36, 55). Given the occurrence of the HAMP–
GGDEF–EAL domain module in many other proteins from different free-living and 
pathogenic bacterial species, the results discussed here will have broad implications 
for receptors predicted to mediate either inside-out or outside-in signaling involving 
the bacterial second messenger c-di-GMP. 
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2.5. Materials and Methods 
Protein expression and purification 
For in vivo experiments, LapD protein variants were expressed from an 
arabinose-inducible vector (pMQ72) in a ΔlapD strain as previously described (24). 
Proteins used in crystallization and in vitro studies were expressed and purified as 
follows. Construct boundaries were chosen based on secondary structure predictions 
and sequence alignments. The coding regions corresponding to the GGDEF-EAL dual 
domain module (LapD
dual
; residues 220-648) and to the isolated EAL domain 
(LapD
EAL
; residues 399-648) of P. fluorescens Pf0-1 LapD were amplified by standard 
PCR and cloned into a modified pProExHtb expression vector (Invitrogen), where the 
TEV protease cleavage site was engineered into a PreScission Protease site for 
removal of the N-terminally fused hexahistidine (His6) moiety. The coding region 
corresponding to the periplasmic output domain of LapD (LapD
output
; residues 22-151) 
was PCR-amplified and cloned into a modified pET28a expression plasmid (Novagen) 
yielding an N-terminally His6-tagged SUMO fusion protein. The His6-tagged SUMO 
moiety was cleavable using the yeast protease Ulp-1. Finally, LapG protein was 
expressed as a C-terminally His6-tagged version after cloning and expression from a 
pET21a expression vector (Novagen).  
Native and selenomethionine-derivatized proteins were overexpressed in E. 
coli, as previously described (14). Briefly, native proteins were expressed in T7 
Express cells (NEB), grown at 37ºC in Terrific Broth (TB) media supplemented with 
50 μg/ml kanamycin for the pET28a vector, or 100 μg/ml ampicillin for the pProEx 
and pET21 vectors. At an optical density corresponding to 0.8-1.2 absorbance at 600 
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nm (OD600), the temperature was reduced to 18ºC and protein expression was induced 
with 1 mM IPTG. Selenomethionine-derivatized proteins were expressed in T7 Crystal 
Express cells (NEB), grown in M9 minimal media supplemented with the appropriate 
antibiotic, vitamins (1 μg/ml thiamin and 1 μg/ml biotin), carbon source (0.4% 
glucose), trace elements, and amino acids (40 μg/ml of each of the 20 amino acids 
with selenomethionine substituting for methionine). Protein expression in minimal 
medium was induced at cell densities corresponding to OD600 of 0.4-0.5. After 16 
hours of expression at 18 degrees, cells were harvested by centrifugation, resuspended 
in NiNTA buffer A (25 mM Tris-HCl, pH 8.4, 500 mM NaCl, and 20 mM Imidazole), 
and flash-frozen in liquid nitrogen. 
After thawing and cell lysis by sonication, cellular debris were removed by 
centrifugation and clear lysates were incubated with NiNTA resin (Qiagen) 
equilibrated in NiNTA buffer A. The resin was washed excessively with buffer A and 
proteins were eluted in a single step of NiNTA buffer A supplemented with 500 mM 
Imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-HCl, pH 
8.4, 300 mM NaCl, and 5 mM β-mercaptoethanol) and, where applicable, affinity tags 
were removed by incubation with the yeast protease Ulp-1 or PreScission Protease at 
4ºC overnight. Cleaved proteins were collected in the flow-through during a second 
step of NiNTA affinity chromatography (HisTrap; GE Healthcare). As a final step of 
protein purification, proteins were concentrated and subjected to size-exclusion 
chromatography on a Superdex200 column (GE Healthcare) equilibrated with gel 
filtration buffer (25 mM Tris-HCl, pH 8.4, and 250-300 mM NaCl). Proteins were 
concentrated on a Centricon ultracentrifugation device with an appropriate molecular 
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weight cut-off (Millipore) to final concentrations in the low milimolar range. Protein 
aliquots were flash frozen in liquid nitrogen and stored at -80ºC.  
 
Crystallization, X-ray data collection, and structure solution 
All crystals were obtained by hanging drop vapor diffusion after mixing equal 
volumes of protein (10-30 mg/ml) and reservoir solution. LapD
dual
 was crystallized 
without cleavage of the N-terminally fused hexahistidine tag. Native and 
selenomethionine-derivatized proteins yielded single crystals grown at 20ºC with 
reservoir solution containing 14% PEG 4000 and 0.1 M MES, pH 6.0 (space group 
P32). In addition, LapD
dual
 yielded crystals with I23 space group symmetry after 
mixing with reservoir solution of 0.2 M Ammonium acetate, 0.1 M Sodium citrate, pH 
5.6, and 15% PEG 4000. For cryoprotection in either case, crystals were soaked in 
reservoir solution supplemented with 30% Ethylene glycol prior to freezing. 
For crystallization of the isolated, untagged EAL domain in the presence of c-
di-GMP, the protein solution was supplemented with 1 mM purified nucleotide prior 
to setting up the crystallization trials. Diffraction-quality crystals with P6522 space 
group symmetry grew after incubation for 7-10 days at 4ºC with well solution 
containing 0.1 M Bis-Tris, pH 6.5, and 1.5 M Ammonium sulfate. Cyclic di-GMP 
bound EAL domain crystals with C2221 symmetry grew at 20ºC in a crystallization 
condition containing 0.1 M Bis-Tris, pH 5.5, 0.2 M Ammonium sulfate, and 24% PEG 
3350. Prior to freezing, the crystals were soaked in their respective reservoir solutions 
supplemented with 25% of the cryoprotectant xylitol.  
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LapD
output
 crystals used for data collection were grown at 4ºC after mixing with 
a reservoir solution containing 22% PEG monomethyl ether 2,000 and 0.15 M 
Potassium bromide. For crystal freezing, the mother liquor was supplemented with 
20% xylitol to ensure cryoprotection. Cryo-preserved crystals for all protein constructs 
were flash-frozen and stored in liquid nitrogen. Data were collected on frozen crystals 
at 100K using synchrotron radiation at the Cornell High Energy Synchrotron Source 
(CHESS). 
Data reduction was carried out with the software package HKL2000 (62) and 
XDS (63). Experimental phases for LapD
dual
 and LapD
output
 crystals were obtained 
from Single Anomalous Diffraction (SAD) experiments on crystals grown from 
selenomethionine-derivatized proteins. Heavy atom positions and solvent flattening 
was carried out by using the software package PHENIX (64). For LapD
dual
, initial 
phases were extended by using the software DM (65), and the first model was built 
into the electron density map automatically by using the software Buccaneer (66). The 
structure of nucleotide-bound LapD
EAL
 was determined by molecular replacement in 
PHENIX with the EAL domain of LapD
dual
 as the search model. Refinement in 
PHENIX and COOT yielded the final models (64, 67). Data collection and refinement 
statistics are summarized in Table 2.1. Illustrations were made in Pymol (DeLano 
Scientific). 
 
Size Exclusion Chromatography–Coupled Static MALS 
For MALS measurements, purified proteins (20–320 µM, injected 
concentration) were subjected to size exclusion chromatography (SEC) using a WTC-
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030S5 (for LapD
dual
) or WTC-015S5 (for LapD
EAL
) column (Wyatt Technology) 
equilibrated in gel filtration buffer (25 mM Tris-HCl [pH 8.4] and 250 mM NaCl). 
Where specified, wild-type or mutant LapD protein variants were incubated with c-di-
GMP (500 µM), produced enzymatically, for 30 min at room temperature prior to 
SEC. The SEC system was coupled to an 18-angle static light scattering detector and a 
refractive index detector (DAWN HELEOS-II and Optilab T-rEX, respectively, Wyatt 
Technology). Data were collected at 25°C every second at a flow rate of 1.0 ml/min 
and analyzed with the software ASTRA, yielding the molecular weight and mass 
distribution (polydispersity) of the samples. For data quality control and normalization 
of the light scattering detectors, monomeric bovine serum albumin (Sigma) was used. 
 
Protein Pull-Down Assay 
His6-tagged LapG was incubated with NiNTA superflow resin (Qiagen) in 
low-salt binding buffer (25 mM Tris-HCl [pH 8.4], 75 mM NaCl, 25 mM KCl, and 40 
mM Imidazole). After removal of any unbound protein in consecutive wash steps, 
untagged LapD output domain variants were added to the reaction and incubated for 1 
h at 4°C under nutation. The resin was extensively washed in low-salt binding buffer. 
The remaining affinity-bound proteins or protein complexes were eluted from the 
slurry in elution buffer (25 mM Tris-HCl [pH 8.4], 500 mM NaCl, and 300 mM 
Imidazole) and visualized using standard denaturing gel electrophoresis (SDS-PAGE). 
For quantification, gels were stained with SYPRO Ruby gel stain (Molecular Probes) 
following the manufacturer's directions, and imaged on a VersaDoc MP system (Bio-
Rad). 
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Strains and Growth Conditions 
Routine culturing of P. fluorescens Pf0-1 and E. coli was done in lysogeny 
broth at 30°C and 37°C, respectively. When appropriate, antibiotics were added to the 
medium at the following concentrations: E. coli, 10 µg/ml gentamicin; P. fluorescens, 
20 µg/ml gentamicin. Plasmids were introduced into P. fluorescens by electroporation 
as described previously (58). K10T medium for biofilm assays was prepared as 
described previously. K10T-π is 50 mM Tris-HCl (pH 7.4), 0.2% (wt/vol) Bacto 
tryptone, 0.15% (vol/vol) glycerol, and 0.61 mM Mg2SO4. K10T-1 medium is K10T-π 
amended with 1 mM K2HPO4. A list of strains and plasmids used in the cell-based 
assays is provided in Table 2.2. 
 
Quantitative Biofilm Formation and Surface Attachment Assays 
To quantify biofilm formation, strains were grown statically for 6 h in K10T-1 
medium as described previously (24). Biofilm biomass was stained with 0.1% crystal 
violet for 15 min, the stain was dissolved, and the biofilm quantified by 
spectrophotometry, measuring the optical density at 550 nm. We analyzed the effects 
of inorganic phosphate starvation on attachment by comparing biofilm levels in high-
phosphate (K10T-1) and low-phosphate (K10T-π) media over time, as done 
previously (24). 
 
Assessment of LapD Protein Levels by Western Blot 
LapD proteins expressed in P. fluorescens Pf0-1 were visualized by Western 
blot as described previously (24), with the following modifications. Blots were probed 
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for the His6 epitope with a rabbit anti-His6 antibody (Genscript). Samples consisted of 
clarified cell lysates prepared by harvesting cells from 3 ml of overnight culture, 
sonicating 3×10s in 500 µl of buffer (20 mM Tris [pH 8] and 10 mM MgCl2), and 
pelleting debris at 15,000g for 12 min. Samples were normalized to protein 
concentration using the BCA kit (Pierce). 
 
Enzymatic production of c-di-GMP 
Cyclic di-GMP used in crystallization trials and c-di-GMP binding assays was 
synthesized enzymatically using a constitutively active WspR mutant (PA3702 R
242
A) 
and GTP as a substrate (18). Following purification by preparative reverse-phase 
HPLC and lyophilization, the nucleotide product was enzymatically tested as a 
substrate for phosphodiesterases (data not shown). Cyclic di-GMP purity and 
concentration were determined based on absorbance at 254 nm in comparison with 
commercially obtained standards (Biolog Life Science Institute).  
 
Accession Numbers 
Atomic coordinates and structure factors have been deposited in the RCSB 
Protein Data Bank (PDB) under the ID codes 3pjt, 3pju, 3pjv, 3pjw, and 3pjx. 
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CHAPTER 3 
 
Structural characterization of a conserved, calcium-dependent periplasmic 
protease from Legionella pneumophila* 
 
3.1. Abstract 
 
The bacterial dinucleotide second messenger c-di-GMP has emerged as a 
central molecule in regulating bacterial behavior, including motility and biofilm 
formation. Proteins for the synthesis and degradation of c-di-GMP and effectors for its 
signal transmission are widely used in the bacterial domain. Previous work established 
that the GGDEF-EAL domain-containing receptor LapD senses c-di-GMP inside the 
cytosol and relays this signal to the outside by the differential recruitment of the 
periplasmic protease LapG. Here we identify the core components of an orthologous 
system in Legionella pneumophila. Despite only moderate sequence conservation at 
the protein level, key features concerning the regulation of LapG are retained. The 
output domain of the LapD-like receptor from L. pneumophila, CdgS9, binds the LapG 
ortholog involving a strictly conserved surface tryptophan residue. While the 
endogenous substrate for L. pneumophila LapG is unknown, the enzyme processed the 
corresponding P. fluorescens substrate, indicating a common catalytic mechanism and 
substrate recognition. Crystal structures of L. pneumophila LapG provide the first 
atomic models of bacterial proteases of the DUF920 family and reveal a conserved 
calcium-binding site important for LapG function. 
*Reproduced with permission from [Debashree Chatterjee, Chelsea D. Boyd, George 
A. O’Toole, and Holger Sondermann (2012) Journal of Bacteriology, 4415–4425] © 
2012 Chatterjee et al. 
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3.1. Introduction 
Bacteria sense and respond to their environment by a multitude of 
physiological programs, allowing them to adapt to changing and often hostile 
conditions. Biofilm formation is one such mechanism that is used widely by many 
pathogenic and environmental bacteria (16). Cyclic  di-GMP, a molecule unique to 
bacteria, has emerged as an important intracellular second messenger that regulates the 
formation of biofilms at multiple levels (17). The majority of the bacterial genomes 
sequenced to date encode enzymes for the production and turnover of c-di-GMP, 
diguanylate cyclases with GGDEF domains, and phosphodiesterases with EAL or HD-
GYP domains, respectively (12). Receptors for c-di-GMP are a less-well-defined 
group that includes receiver domains in transcription factors, PilZ domain-containing 
proteins, riboswitches, and proteins with catalytically inactive GGDEF or EAL 
domains constituting a distinct class (36). These proteins exploit their degenerate 
active sites or regulatory c-di-GMP binding sites to sense the cellular concentration of 
the dinucleotide and to solicit a specific response. 
One such receptor, the transmembrane protein LapD from Pseudomonas 
fluorescens, contains both catalytically inactive GGDEF and EAL domains, with the 
latter serving as the exclusive c-di-GMP binding module (31). Previous work 
established LapD as a prototypical receptor for mediating inside-out signaling from the 
cytosol to the periplasm. LapD responds to a rise in c-di-GMP levels triggered by the 
availability of Pi, by undergoing a conformational change from a nucleotide-free, 
autoinhibited state to a c-di-GMP-activated state (19, 28–30) (Fig. 3.1A). Only the 
activated state is capable of sequestering a periplasmic protease, LapG, to LapD’s 
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output domain which, in turn, stabilizes LapG’s substrate, LapA (30). LapA is a large 
adhesin protein that is embedded in the outer membrane (18). Proteolytic processing 
by LapG releases LapA from the membrane, leading to biofilm dispersion when Pi is 
limiting (30). In conjunction with revealing the signaling and output system for 
biofilm formation in P. fluorescens, we determined the crystal structures of the 
functional domains of LapD spanning almost the entire receptor (29). These studies 
revealed the main regulatory features controlling LapD function. Based on a 
bioinformatic analysis, we also identified orthologous signaling systems in many other 
bacteria. Two of those have been characterized independently in Pseudomonas putida 
and Shewanella oneidensis (14, 37). 
Another orthologous system that we predicted, based on bioinformatics, is that 
of Legionella pneumophila, the causative agent of Legionnaires’ disease (29). Unlike 
Pseudomonas, L. pneumophila is a facultative intracellular bacterium that is also able 
to grow in biofilms. Its genome encodes 21 predicted proteins with GGDEF and/or 
EAL domains and a single PilZ protein, and a subset of these have been shown to 
impact intracellular growth, motility, or biofilm formation (5, 25, 34). However, the 
underlying signaling mechanisms and networks and their regulation are largely 
unknown for the majority of these proteins. 
In this study, we focused on the periplasmic protease LapG of L. pneumophila, which 
belongs to the domain of unknown function 920 (DUF920) (or COG3672) family, and 
hence, little is known regarding its molecular mechanism. Sequence and fold 
recognition methods classified these proteins as bacterial transglutaminase-like 
cysteine proteases (BTLCPs) and predicted a cysteine-histidine-aspartate (C-H-D) 
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catalytic triad and core structural motif at the active site (13). O’Toole and colleagues 
corroborated the notion that LapG functions as a cysteine protease (30). In an effort to 
further our mechanistic understanding of LapG and related proteases, we determined 
crystal structures of the LapG ortholog from L. pneumophila. In a parallel study, the 
O’Toole group noted a dependence of P. fluorescens LapG activity on calcium ions 
(4), and the structures allowed us to identify a strictly conserved calcium-binding site 
in LapG and BTLCPs. In addition, we demonstrate that the L. pneumophila LapD-
LapG system utilizes an output mechanism similar to that which we previously 
described in P. fluorescens (29, 30). 
 
Figure 3.1: The LapADG signaling system.  
(A) Model of LapD-mediated regulation of biofilm formation in P. fluorescens. The c-
di-GMP receptor LapD localizes to the inner membrane (IM), where it senses 
cytoplasmic c-di-GMP levels. It controls the stability of the large adhesin LapA in the 
outer membrane (OM) by sequestration of the periplasmic protease LapG. The  
underlying signaling pathway is controlled by the availability of Pi.
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3.2. Materials and Methods 
Protein expression and purification 
DNA fragments encoding L. pneumophila LapG lacking the signal peptide 
(lpg0828; residues 52 to 244) and the periplasmic output domain of the LapD ortholog 
CdgS9 (lpg0829; residues 22 to 152) were amplified from genomic DNA by standard 
PCR and cloned into a bacterial expression vector based on pET28a (Novagen) that 
adds an N-terminal, cleavable His6-SUMO tag (Table 3.1). 
          Native and selenomethionine-derivatized proteins were overexpressed in 
Escherichia coli BL21 T7 Express or T7 Express Crystal cells (New England 
BioLabs), respectively. For the expression of native proteins, cultures were grown at 
37°C in terrific broth medium supplemented with 50 µg/ml kanamycin. At an optical 
density at 600 nm (OD600) of ~1, the temperature was reduced to 18°C and protein 
expression was induced by adding 1 mM IPTG. Selenomethionine-derivatized proteins 
were expressed in cells grown at 37°C in M9 minimal medium supplemented with 50 
µg/ml kanamycin, vitamins (1 µg/ml thiamine and 1 µg/ml biotin), a carbon source 
(0.4% glucose), trace elements, and amino acids (each of the 20 amino acids at 40 
µg/ml, with selenomethionine substituting for methionine). Protein expression was 
induced at an OD600 of 0.4 to 0.5. In both cases, protein expression proceeded for 16 h 
at 18°C, after which cells were harvested by centrifugation, resuspended in Ni-
nitrilotriacetic acid (NTA) buffer A (25 mM Tris-HCl [pH 8.5], 500 mM NaCl and 20 
mM imidazole), and flash frozen in liquid nitrogen. Cell suspensions were thawed and 
lysed by sonication. Cell debris was removed by centrifugation, and the clear lysates 
were incubated with Ni-NTA resin (Qiagen) that was pre-equilibrated with Ni-NTA 
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buffer A. The resin was washed with 20 column volumes of buffer A, followed by 
protein elution with 5 column volumes of Ni-NTA buffer B (25 mM Tris-HCl [pH 
8.5], 500 mM NaCl and 300 mM imidazole). The eluted proteins were buffer 
exchanged into a low-salt buffer (25 mM Tris-HCl [pH 8.5] and 150 mM NaCl) on a 
fast desalting column (GE Healthcare). Proteins were subjected to size exclusion 
chromatography on a Superdex 200 column (GE Healthcare) pre- equilibrated with gel 
filtration buffer (25mMTris-HCl [pH 8.5] and 150 mM NaCl). Where indicated, the 
His6-SUMO moiety was cleaved off by using the yeast protease Ulp-1 following 
desalting. Ulp-1, uncleaved protein, and the cleaved fusion tags were removed by Ni-
NTA affinity chromatography prior to the final gel filtration. Purified proteins were 
concentrated on Amicon filters with an appropriate size cut-off to concentrations of 25 
mg/ml, flash frozen in liquid nitrogen, and stored at -80°C. 
The expression and purification of the corresponding proteins from P. 
fluorescens were described previously (29). The construction, expression, and 
purification of P. fluorescens LapA
Nterm
 were described elsewhere (30). Site-directed 
mutagenesis was carried out by using the QuikChange kit (Agilent Technologies) and 
following the manufacturer’s instructions. 
 
Crystallization, data collection, and structure solution 
Crystals were obtained by hanging-drop vapor diffusion mixing equal volumes 
of protein (10 to 30 mg/ml) and reservoir solution, followed by incubation at 4°C. For 
the native, apo-state crystal form, the reservoir solution contained 0.14 M ammonium 
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tartrate dibasic and 20% polyethylene glycol 3350. The selenomethionine-derivatized 
protein crystallized in the same condition supplemented with 0.1 M Bis-tris (pH 7.0). 
Crystals for calcium-bound and EGTA-treated LapG were obtained in the same 
condition as the apo-protein, supplemented with 2 mM CaCl2 and EGTA, respectively. 
For cryoprotection, crystals were soaked in reservoir solution supplemented with 25% 
xylitol. Cryopreserved crystals were flash frozen and stored in liquid nitrogen. For 
optimal diffraction, crystals of LapG-Ca
2+
 were grown at 20°C and transferred to 4°C 
for 1 h prior to cryoprotection and freezing. Data on frozen crystals were collected at 
100 K using synchrotron radiation at the Cornell High Energy Synchrotron Source 
(CHESS; Cornell University, Ithaca, NY). 
Data reduction was carried out with the software package HKL2000 (33). 
Experimental phases for the initial structure determination were obtained from single-
wavelength anomalous diffraction (SAD) experiments with crystals grown from 
selenomethionine-derivatized proteins by using the software package PHENIX (2). 
Refinement in PHENIX and COOT (11) yielded the final models. Data collection and 
refinement statistics are summarized in Table 3.2. Illustrations were made in Pymol 
(Schrödinger). Alignments were generated using ClustalW2 (24) and formatted with  
ESPript (15). Sequence logos were generated using WebLogo (8, 35). 
 
Protein pull-down assay  
His6-SUMO-tagged L. pneumophila LapG or His6-tagged P. fluorescens LapG 
was incubated with Ni-NTA resin (Qiagen) for 1 h at 4°C in binding buffer (25 mM 
Tris-HCl [pH 8.5], 75 mM NaCl, 25 mM KCl and 40 mM imidazole). Following the   
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Table 3.1. Strains and plasmids used in this study. 
Strain or plasmid Genotype or Description Reference 
Escherichia coli   
Top-10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG 
Invitrogen 
T7 Express cells 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10 
NEB 
T7 Express Crystal cells 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 metB1 Δ(mcrC-
mrr)114::IS10 
NEB 
Plasmids   
pET21a E. coli expression vector, Amp
R
 Novagen 
pET28a E. coli expression vector, Kana
R
 Novagen 
pET28-His6-SUMO pET28 expressing His6-SUMO, Kana
R
 This study 
pET21-Pfl-LapG 
pET21 expressing P. fluorescens LapG 
(Pfl0130), residues 50-251, Amp
R
 
(1) 
pSUMO-Lpg-LapG 
pET28 expressing L. pneumophila LapG 
(Lpg0828), residues 52-244, fused to His6-
SUMO at its N-terminus, Kana
R
 
This study 
pSUMO-Pfl-LapD
output
 
pET28 expressing P. fluorescens LapG 
(Pfl0131), residues 52-244, fused to His6-
SUMO at its N-terminus, Kana
R
 
(1) 
pSUMO-Lpg-CdgS9
output
 
pET28 expressing L. pneumophila CdgS9 
(Lpg0829), residues 22-152, fused to His6-
SUMO at its N-terminus, Kana
R
 
This study 
pLapA
Nterm
 pMQ72 expressing N-term-LapA, Gm
R
 (2) 
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three washing steps with 5 column volumes of binding buffer each, LapG-bound resin 
(corresponding to ~50 µg of protein) was incubated with an excess of the untagged 
output domain (250 µg or 20 µM) of either L. pneumophila or P. fluorescens LapD for 
30 min at 4°C. After the resin was washed three times with 5 column volumes of 
binding buffer, proteins were eluted from the resin with elution buffer (25 mM Tris-
HCl [pH 8.5], 500 mM NaCl and 300 mM imidazole). Eluates were analyzed using 
standard denaturing SDS-PAGE and Coomassie staining. All incubations were carried 
out under gentle agitation in spin columns. 
 
LapA cleavage assay 
Purified P. fluorescens LapG variants (wild type or D
136
A; 0.4 µM) and L. 
pneumophila LapG variants (wild type, D
136
A, E
138
A, or D
139
A; 40 to 150 µM) were 
incubated at the indicated concentrations with purified LapA
Nterm
 (2 µM) in reaction 
buffer (25 mM Tris-HCl [pH 8.5], 150 mM NaCl and 20 mM MgCl2) overnight at 
room temperature in the presence or absence of 10 mM EGTA. The reaction products 
were separated by SDS-PAGE and analyzed by Western blotting using a monoclonal 
antibody raised against pentahistidine (Qiagen) which was detected by a horseradish 
peroxidase-coupled anti-mouse antibody. Blots were developed by using enhanced 
chemiluminescence (GE Healthcare) and exposed to film. 
 
Size Exclusion Chromatography-Multi Angle Light Scattering 
          Size exclusion chromatography-coupled multiangle light scattering (SEC-
MALS) measurements were carried out by injecting purified proteins (100 µM) onto a 
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WTC-030S5 gel filtration column (Wyatt Technology) pre-equilibrated with gel 
filtration buffer (25 mM Tris-HCl [pH 8.5] and 150 mM NaCl). The SEC system was 
coupled to an 18-angle, static light scattering detector and a refractive index detector 
(DAWN HELEOS-II and Optilab T-rEX, respectively; Wyatt Technology). Data were 
collected at 25°C every second at a flow rate of 1 ml/min and analyzed with the 
software ASTRA, yielding the molecular mass and mass distribution (polydispersity) 
of the samples. For data quality control and normalization of the light scattering 
detectors, monomeric bovine serum albumin (Sigma) was used. 
 
Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) was used to determine the apparent 
dissociation constant (Kd) and the stoichiometry of interactions using a VP calorimeter 
(Microcal). Calorimetric titrations of calcium (2 mM in the syringe; 10 µl injections) 
and wild-type or mutant L. pneumophila LapG (200 µM in the cuvette) were carried 
out at 20°C in gel filtration buffer (25 mM Tris-HCl [pH 8.5] and 150 mM NaCl) with 
a delay of 300s between injections. The data obtained were analyzed by integrating 
heat effects normalized to the amount of injected protein and curve fitting based on a 
single-site binding model by using the Origin software package (Microcal). 
 
Protein structure accession numbers 
Coordinates and structure factors have been deposited in the Protein Data Bank  
(PDB) and assigned accession numbers 4FGQ, 4FGP, and 4FGO.
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 3.3. Results 
The Lap operon in L. pneumophila 
          We previously predicted the existence of proteins with sequence similarity to P. 
fluorescens LapD and LapG in several bacterial species, including L. pneumophila 
(29). In silico genomic analysis indicates that both genes map to an operon containing 
at least five genes (Fig. 3.2). It encodes a predicted type I secretion outer membrane 
protein (lpg0827/TolC), a LapG-like protease (lpg0828), a LapD ortholog with a 
degenerate GGDEF-EAL domain module (lpg0829/CdgS9), and two putative proteins 
(lpg0830, predicted thioesterase/lipase activity; lpg0831, predicted flavin-containing 
monooxygenase). While the functional relevance of the latter two gene products 
within this cluster remains to be established, a type I secretion system is required in P. 
fluorescens for the translocation of the LapG substrate to the outer membrane (18), 
and L. pneumophila TolC may fulfill a similar function. Considering the limited 
mechanistic characterization of DUF920-containing proteins and the importance of 
LapG as a part of a c-di-GMP-dependent signaling system (29, 30), we set out to 
determine the molecular mechanism and structure of a LapG ortholog. 
 
Figure 3.2: The Lap operon in L. pneumophila.  
Genetic map of the LapD ortholog containing operon in L. pneumophila. 
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Conservation of the LapD-LapG interaction in L. pneumophila 
To establish that the LapG and LapD orthologs indeed form a complex as part 
of a regulatory system, we purified the periplasmic output domain of L. pneumophila 
CdgS9 (the LapD ortholog) and LapG. Both proteins were expressed most stably with 
cleavable, N-terminal hexahistidine-SUMO (His6-SUMO) tags. For comparison, we 
used the respective protein constructs from P. fluorescens, with the exception that 
LapG contained a C-terminal His6 tag instead of the His6-SUMO tag (29). We 
previously demonstrated that the interaction between P. fluorescens LapG and LapD 
relies on a strictly conserved tryptophan residue that is present at the tip of a beta-
hairpin motif in LapD’s output domain (29) (Fig. 3.3A). Mutation of this residue to 
glutamate abolished LapG binding and signaling through LapD, serving as an 
invaluable specificity control. 
          His6-tagged (or His6-SUMO-tagged) LapG orthologs were bound to Ni-NTA 
Sepharose, washed, and incubated with the purified, untagged output domain of LapD 
or CdgS9, respectively. Proteins were eluted and analyzed by SDS-PAGE. Despite 
overall low sequence conservation of LapD orthologs (~23% across the entire 
receptor), P. fluorescens LapG adsorbed not only the cognate LapD output domain but 
also equally efficiently the corresponding domain of the L. pneumophila ortholog (Fig. 
3.3B). A similar complex formation by L. pneumophila LapG and the corresponding 
LapD output domain was observed. Binding of L. pneumophila LapG to the output 
domain of P. fluorescens LapD was detectable but weaker. All interactions were 
sensitive to a non-conservative (W-to-E) mutation at the critical tryptophan residue at 
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the center of the output domain beta-hairpin motif, indicating that the mode of binding 
is specific and conserved across distantly related bacterial species (Fig. 3.3B). 
 
 
 
Figure 3.3: Conserved interaction of LapD and LapG.  
(A) Sequence conservation of a loop in the periplasmic output domain of LapD (PDB 
code 3PJV) that is critical for LapG interaction in P. fluorescens.  
(B) Interaction between LapD’s output domain with LapG: Purified, His6-tagged LapG 
was bound to Ni-NTA and incubated in the absence or presence of the untagged LapD 
output domain. Proteins from P. fluorescens (Pfl) or L. pneumophila (Lpg) were used. 
A specific output domain mutation (W
125
E in P. fluorescens LapD; W
126
E in L. 
pneumophila CdgS9) was included. Eluted complexes were analyzed by SDS-PAGE,   
followed by Coomassie staining.
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The crystal structure of L. pneumophila LapG 
The LapG ortholog from L. pneumophila (residues 52 to 244; lacks the signal 
peptide) was expressed in E. coli as a soluble protein and purified by standard liquid 
chromatography. Upon crystallization (space group P21212; two molecules per 
asymmetric unit), the high-resolution structure was determined by SAD phasing with 
selenomethionine-substituted protein crystals (Fig. 3.5A; Table 3.2). 
The structure reveals a bilobal fold of LapG (Fig. 3.5A). The N-terminal lobe 
is formed by five α-helices folding into a globular structure. In contrast, the C-terminal 
lobe consists of a five stranded anti-parallel β-sheet. The three central strands are 
longer than the two flanking strands. The extreme C terminus folds into a helix that is 
connected to the bulk of the protein by a flexible linker and is buttressed by the N-
terminal lobe via largely hydrophobic interactions. The strictly conserved active site, 
the C-H-D catalytic triad (C
137
, H
172
, D
189
; Fig. 3.5B), is located at the interface 
between the two halves of the protein, with the histidine and aspartate residues being 
contributed by the C-terminal lobe and the catalytic cysteine residue by the central 
helix  α5 of the N-terminal lobe (Fig. 3.5A). The hydroxyl group of a serine residue 
(S
190
) points toward the active site and engages in a hydrogen bond with D
189
 of the 
catalytic triad.  
The catalytic triad is equally conserved within the LapG subgroup and all 
BTLCPs. The residue corresponding to position 190 in L. pneumophila LapG can be 
either a serine or an asparagine residue in the LapG subset, as well as the wider 
BTLCP family (Fig. 3.5B). In order to more globally visualize the conservation of 
LapG-type proteases, we mapped the conservation scores of 24 LapG orthologs onto 
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the accessible surface of the protease fold. Orthologs from distantly related species, 
including Pseudomonas, Legionella, and Vibrio species, were used to create the 
alignment for this analysis (Fig. 3.4). Interestingly, not only is the catalytic triad 
strictly conserved, but we also noted a fairly conserved surface patch extending from 
the active site (Fig. 3.5C). While the functional relevance remains to be established, 
the hydrophobic nature of this region may suggest a role as an interaction interface, for 
example, for substrate binding, considering its close proximity to the active site. 
A structural role can be attributed to several hydrophilic residues. Consistent 
with the bioinformatic and modeling study of BTLCPs (13), in addition to the 
invariant catalytic triad, there are several conserved, polar, or charged residues that 
form a hydrogen bond network stabilizing some of the core secondary structure 
elements adjacent to the active site (N
91
, N
95
, K
130
, and N
173
 in BTLCP; N
102
, N
106
, 
K
144
, and the aforementioned S
190
 in L. pneumophila LapG) (Fig. 3.6). Residues with 
similar function but more specific to the LapG subfamily of BTLCPs are R
201
 and D
203
 
(Fig. 3.5B), located in the C-terminal lobe (Fig. 3.5A). Positioned by D
203
, R
201
 
coordinates D
189
 of the catalytic triad. Together, these residues are part of the 
hydrogen bond network that coordinates D
189
 at the active site. 
A comparison against the entire PDB using the DALI server (20) was used to 
identify structurally related proteins. With the structure of L. pneumophila LapG as the 
search model (Fig. 3.7A), we identified eukaryotic protein transglutaminases as some 
of the closest structural neighbors (Fig. 3.7B; PDB codes 1g0d, 1kv3, 1ggt, and 1nud) 
(3, 27, 32, 40). In addition, the search identified an arylamine N-acetyltransferase (Fig. 
3.6C; PDB code 2bsz) (21) and putative bacterial cysteine proteases (Fig. 3.7D and E; 
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PDB codes 3isr and 3kd4) with deposited structures but no associated publication as 
proteins that contain a similar fold. All but one protein (the putative bacterial protease 
with PDB code 3kd4) display a catalytic triad that is conserved in sequence (C-H-D) 
and position relative to that of LapG, with the cysteine residue being located at the tip 
of the central helix (Fig. 3.7). Notably, the activity of several transglutaminases 
depends on the presence of calcium ions (1, 41), and calcium-binding sites have been 
identified in a subset of crystal structures and by modeling approaches (e.g., PDB code 
1nud; Fig. 3.7B) (3, 6, 9). These studies identified three distinct calcium-binding sites 
in the human transglutaminase 3 enzyme with site 1 being located adjacent to the 
active site. For transglutaminase, this site has been proposed to stabilize the enzyme, 
yet a similar role in LapG could not be established. However, P. fluorescens LapG is 
sensitive to EGTA treatment and requires calcium ions for the specific cleavage of its 
substrate, LapA (4), suggesting a crucial function during catalysis.
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Figure 3.4: Sequence alignment of LapG orthologs.  
A sequence alignment of LapG-like proteins from various species was generated. Key 
residues discussed in the manuscript are marked and colored according to the main 
figures. The following sequences were used to generate the alignment: L. pneumophila 
Philadelphila 1 (LPG_0828), L. pneumophila Lens (LPL_0859), Bordetella 
parapertussis (BPP_0973), B. bronchiseptica (BB_1185), P. fluorescens Pf0-1 
(PFL_0130, PFL01_0130), P. putida KT2440 (PP_0164), P. aeruginosa PAO1 
(PA_1434), P. entomophila (PSEEN_0138), Vibrio cholerae O1 biovar El Tor 
N16961 (VC_A1081), V. cholerae 1587 (A55_A0980), Pectobacterium atrosepticum 
(ECA_3263), Desulfotalea psychrophila (DP_0518), Chromobacterium violaceum 
(CV_0309), Aromatoleum aromaticum EbN1 (EBA_1785), Rhodoferax ferrireducens 
(RFER_3763), Shewanella denitrificans (SDEN_0379), V. fischeri ES114 
(VF_A1167), V. vulnificus CMCP6 (VV2_1126), Thiomicrospira crunogena 
(Tcr_0209), Photobacterium profundum (PBPRB_0581), Polaromonas sp. JS666 (BP 
RO_0309), Methylibium petroleiphilum (Mpe_A1879), V. parahaemolyticus 
(VPA_1734).
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Table 3.2: X-ray data collection and refinement statistics. 
 LapG, apo LapG, apo LapG•Ca2+ LapG•EGTA 
 
(selenomethioni
ne) 
(native) 
(selenomethionin
e) 
(native) 
Data Collection 
X-ray source CHESS, A1 CHESS, A1 CHESS, A1 CHESS, A1 
Wavelength (Å) 0.9771 0.9771 0.9771 0.9771 
Space group P21212 P21212 P43212 C2 
Unit cell     
a, b, c  (Å) 
100.9, 104.5, 
43.8 
100.9, 105.1, 
43.3 
60.0, 60.0, 110.4 123.8, 43.7, 100.7 
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 122.1, 90 
Resolution (Å)
a 50-2.0 (2.04-
1.97) 
50-1.7 (1.71-
1.65) 
50-1.9 (1.97-
1.90) 
50-1.7 (1.79-
1.73) 
No. of reflections     
Total 
406,849 
(26,517) 
414,388 
(26,665) 
40,642 (20,120) 195,054 (9,471) 
Unique 33,274 (3,048) 55,010 (4,938) 16,128 (1,315) 45,446 (3,266) 
Completeness 
(%) 
98.9 (92.4) 96.8 (88.5) 97.7 (81.3) 95.3 (69.6) 
Redundancy 12.2 (8.7) 7.5 (5.4) 25.2 (15.3) 4.3 (2.9) 
I/σ(I) 31.3 (4.8) 22.8 (1.9) 49.3 (2.5) 21.3 (2.0) 
Rmeas (%) 8.5 (33.5) 7.7 (72.7) 5.9 (47.5) 6.1 (37.0) 
Refinement 
Rwork / Rfree (%) 18.9 / 22.0 25.9 / 26.7 17.7 / 20.7 
rms deviations    
Bond length (Å) 0.006 0.008 0.006 
Bond angles (°) 1.095 1.111 1.067 
No. of atoms    
Protein 2910 1440 2984 
Water 505 35 453 
Ave. B-factors 
(Å
2
) 
   
Protein 22.3 62.7 25.0 
Water 35.5 49.7 32.7 
Ramachandram 
(%) 
   
Favored 98.6 95.5 96.9 
Allowed 1.4 4.5 2.5 
Disallowed 0 0 0.6 
(a) Values in brackets are for the highest resolution bin. 
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Figure 3.5: Crystal structure of L. pneumophila LapG.  
(A) Cartoon presentation of the LapG fold: The N- and C-terminal lobes are shown in 
slate and cyan, respectively. The conserved catalytic triad (cysteine-histidine-aspartate; 
C-H-D) is shown as sticks with the carbon atoms in orange. The electron density map 
at the active site (bottom left inset) has amplitudes of 2|Fo| to |Fc|, with Fo and Fc being 
the observed and calculated structure factors. The electron density contour is at 1.8 σ. 
Water molecules are shown as red spheres. A hydrogen bond network involving 
residues of the catalytic triad is shown (bottom right inset).  
(B) Conservation of the catalytic triad based on the sequence alignment shown in Fig. 
3.3: Separate sequence logos are shown for the LapG subfamily and the wider family 
of bacterial transglutaminase-like cysteine proteases (BTLCPs), which was generated 
based on an alignment that covers a representative, nonredundant set of sequences.  
(C) Surface conservation and hydrophobicity: Based on the alignment of 24 sequences 
of LapG orthologs, the sequence conservation was mapped to the accessible surface 
(left). In the right panel, the surface is colored according to the hydrophobicity of 
accessible residues. Hydrophobic residues are shown in green, and polar and charged  
residues are gray and pink, respectively.
113 
 
 
 
 
 
Figure 3.6: Conservation of a hydrogen bond network around the catalytic triad. 
(A) Residues from the N- and C-terminal lobes involved in a hydrogen bond network 
around the active site are shown as sticks.  
(B) Sequence conservation: Sequence logos for LapG orthologs and the entire BTLCP  
family are shown.
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Figure 3.7: Structural similarities of LapG to transglutaminases, arylamine N-
acetyltransferases, and putative bacterial proteases.  
A DALI protein structure database search highlighted features structurally conserved 
between LapG (A) and distinct classes of proteins. Regions corresponding to the N 
and C lobes of LapG, are in red and pink respectively, in panels B to E. Conserved 
catalytic (C-H-D) triads are shown as orange spheres. Calcium ions are shown as 
green spheres.  
(B) Human transglutaminase 3: Z score, 7.4; rmsd, 3.6; aligning fragment spans 135 of 
673 residues. Several transglutaminases were identified. The particular structure was 
chosen to highlight the positions of calcium-binding sites in these enzymes.  
(C) Mesorhizobium loti arylamine N-acetyltransferase 1: Z score, 7.8; rmsd, 3.6; 
aligning fragment spans 127 of 267 residues.  
(D) Putative cysteine protease from Cytophaga hutchinsonii: Z score, 9.4; rmsd, 3.1; 
aligning fragment spans 121 of 285 residues.  
(E) Putative protease from Parabacteroides distasonis ATCC 8503: Z score, 7.8;  
rmsd, 3.2; aligning fragment spans 121 of 505 residues.
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Crystal structures of calcium-bound and EGTA-treated LapG 
Incited by the observation that P. fluorescens LapG’s activity depends on 
calcium (4) yet no bound calcium ion was apparent in the crystal structure, we initially 
used pattern prediction algorithms with the apo-LapG structure as the input. The MUG 
calcium-binding site prediction server (38) identified a patch of four conserved, 
negatively charged residues adjacent to the catalytic triad that had the potential to 
accommodate a calcium ion (Fig. 3.8A). While not identical in exact position, the 
predicted site is as close to the active site as is calcium-binding site 1, which was 
found to be crucial for transglutaminase function (Fig. 3.7B). In LapG, three of the 
residues, D
136
, E
138
, and D
139
, flank C
137
 of the catalytic triad, whereas the fourth 
residue (D
120
) is less conserved and farther away with regard to the primary sequence 
(Fig. 3.8A). However, other aspartate or glutamate residues are located in close 
proximity to D
120
 and could function redundantly (Fig. 3.8A). While both the N- and 
C-terminal lobes contribute residues to the catalytic triad, the calcium-binding site is 
located entirely in the N-terminal lobe. This motif is not unique to LapG-like proteins 
but appears to be conserved in the entire BTLCP family on the basis of sequence 
alignments (Fig. 3.8A), indicating a general molecular mechanism of these proteases. 
To confirm the prediction, we crystallized L. pneumophila LapG in the 
presence of calcium ions, yielding a new crystal form. We solved the structure by 
SAD phasing (space group P43212; one molecule per asymmetric unit; Table 3.2). 
While the maximum resolution was 1.9 Å, crystals diffracted X-rays anisotropically 
with a resolution of ~2.8 Å in the worst orientation. This observation is consistent with 
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poor packing interactions along one crystal axis and with the two N-terminal helices 
being poorly resolved (with high B factors for residues 58 to 88; data not shown). 
The overall fold of LapG in the new crystal form was preserved (Fig. 3.9; 
[rmsd] with or without calcium of 0.6 Å). We observed clear density around the 
residues predicted to form the calcium-binding site (Fig. 3.8B, inset). A model with a 
calcium ion at that site refined well. Furthermore, the coordination of the ion by the 
protein side chains is in good agreement with other calcium binding motifs, revealing 
seven ionic or polar interactions, including one water-mediated contact and a carbonyl 
backbone contact with Y
122
 (Fig. 3.8B). To accomplish this, only the side chain of D
120
 
had to adopt an alternative rotamer conformation, flipping toward the binding site, 
while the other three residues are essentially in the same conformation as in the apo-
state structure. We noticed only a small shift of the D
120
-presenting loop relative to the 
body of LapG. However, we cannot distinguish whether this change is calcium 
induced or due to the altered packing interactions in this crystal form. 
We also crystallized LapG treated with EGTA (Table 3.2). This protein 
preparation crystallized in the original condition. While we obtained crystals within 
the same space group as LapG without EGTA treatment, it also crystallized in a 
second space group under identical conditions and similar crystal packing. We solved 
the structure by molecular replacement using the first LapG crystal structure as the 
search model. The structure of the EGTA-treated monomer is almost identical to the 
initial calcium-free state (rmsd of 0.12 Å; Fig. 3.9), and very similar to the calcium- 
bound state despite differences in crystal contacts. 
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Figure 3.8: Structural identification of a conserved calcium-binding site in LapG. 
(A) Position of a putative calcium-binding site in LapG: Sequence conservation 
indicates that at least 3 of the 4 residues predicted to form an ion-binding site are 
conserved in LapG and BTLCPs.  
(B) Crystal structure of calcium-bound LapG: The crystal structure of LapG (gray) 
was determined in the presence of calcium ions (pink sphere). The left inset shows 
uninterpreted electron density that was observed only in the presence of calcium. The 
density has amplitudes of |Fo| to |Fc| and is contoured at 3.6 σ prior to the inclusion of 
calcium in the refinement. The structure of non-calcium-bound LapG was 
superimposed. On the right, a close-up view of the calcium-binding site and calcium  
coordination is shown.
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Figure 3.9: Superposition of L. pneumophila LapG crystal structures.  
The protomers of the three crystal structures (protein purified from E. coli, “apo”; 
calcium-bound protein; EGTA-treated protein) were superimposed on all residues.  
Structural models are shown as Cα traces. 
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Calcium binding by L. pneumophila LapG 
To further validate and quantify calcium binding, we turned to isothermal 
titration calorimetry. The titrations of calcium into a solution of LapG protein are 
shown in Fig. 3.10. Purified protein bound calcium sub-stoichiometrically with 0.6 
calcium molecule per molecule of LapG and with an affinity of 6.2 µM (Fig. 3.9A; 
Table 3.3). EGTA treatment and repurification of LapG by gel filtration in EGTA-free 
buffer as the mobile phase yielded protein that bound calcium with the same affinity 
and negative change in enthalpy as the starting material but with a stoichiometry of 
close to 1 (Fig. 3.10A; Table 3.3). Together, these data indicate that LapG purifies 
partially bound to calcium, which can be extracted by EGTA treatment, yielding 
calcium-free LapG. Based on the titration data, we expect only one calcium-binding 
site per LapG monomer. Given that no bound calcium was observed in the initial 
crystal structure, we infer that the crystallization conditions are sensitive to the 
calcium-bound state of LapG. Finally, mutations in the key residues for calcium 
coordination (D
136
A, E
138
A, or D
139
A) that were revealed by the crystal structure 
significantly reduce calcium binding by factors of  ~50 (Fig. 3.10B), well within the 
range one would expect on the basis of similar mutations in other calcium-binding 
proteins (39). In summary, the structural studies elucidate the overall fold, catalytic 
core machinery, and a calcium-binding site as conserved features of LapG-like  
proteases and members of the wider BTLCP superfamily.
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Table 3.3. Calcium binding measured by isothermal titration calorimetry. 
L. pneumophila LapG n
b
 Kd (M) H (cal/mole) S (cal/mole/deg) 
wild-type 0.59 ± 0.003 6.17 ± 0.22 -1615 ± 10.0 18.3 
EGTA-treated wild-type 0.91 ± 0.005 4.98 ± 0.32 -1720 ± 13.0 18.4 
D
136
A 0.95 ± 0.142 349.7 ± 59.3 -2700 ± 569.9 6.6 
E
138
A N.D. N.D. N.D. N.D. 
D
139
A N.D. N.D. N.D. N.D. 
N.D. not detected. 
 
Figure 3.10: Isothermal titration calorimetry data for calcium binding to LapG.  
(A) Binding of calcium to wild-type L. pneumophila LapG: Calorimetric titration for 
calcium (2 mM) titrated into LapG (0.2 mM) is shown (top, raw data; bottom, binding 
isotherms). LapG purified from E. coli was used with or without EGTA treatment 
during its purification.  
(B) Binding of calcium to mutant LapG forms: Single-point mutations were introduced 
into the calcium-binding site of LapG and analyzed as described for panel  
A. Data analyses are summarized in Table 3.3. 
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Oligomeric state of LapG in solution  
It can be assumed that the transmembrane receptor LapD, which interacts with 
LapG, forms a constitutive homodimer mediated at least by its HAMP domains, a two-
helix module that forms a four-helix bundle within a dimeric assembly as the 
functional unit. This prompted us to analyze the oligomeric state of LapG in the 
crystals and in solution. 
Two different crystal forms of calcium-free LapG were obtained, both with 
two molecules in their asymmetric units (rmsd of protomer A versus protomer B, 0.08 
Å). A potential dimer interface can be identified on the basis of crystal packing 
interactions. Although the protomer interactions are identical in the two forms (rmsd 
considering dimeric assemblies, 0.17 Å), the interface is marginal, spanning only 670 
Å
2
. In both crystal forms, protomers interact via a hydrophobic interface formed by the 
β-sheets of the C-terminal lobe (Fig. 3.11A). Another part of the interface in the 
crystallographic dimer is presented by the loop protruding from the N-terminal lobe 
that contains a residue involved in calcium binding (D
120
), in addition to the conserved 
residue, D
113
. However, the overall packing and calculated binding enthalpies suggest 
that the dimerization interface is rather weak overall (23). 
          We next evaluated LapG’s oligomerization propensity in solution by using 
purified proteins. We used SEC-MALS, a method that yields the absolute molecular 
mass of a protein as it is eluted from a gel filtration column (10). L. pneumophila 
LapG purified from E. coli is monomeric in solution with a molecular mass of ~25 
kDa (theoretical molecular mass based on sequence, 21.6 kDa; Fig. 3.11B). There was 
no change in its monomeric state when the protein was incubated with calcium prior to 
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SEC-MALS analysis or even when calcium was added to the mobile phase, so that 
calcium was present throughout the experiment. 
While we observed only monomeric LapG in solution, the crystallographic 
dimer interface is moderately conserved across various bacterial strains (Fig. 3.4 and 
3.5C), which could suggest that a subset of LapG-like orthologs may utilize this 
surface. Also, considering that the receptor LapD forms constitutive dimers (29), such 
a mode of LapG dimerization may still be relevant when LapG is bound to the output 
domains of intact LapD. 
 
Conservation of the basic catalytic mechanism of LapG  
Unlike in the case of P. fluorescens, the LapG-containing operon in L. 
pneumophila lacks a putative LapA-like substrate protein. Although the identity of the 
substrate for the L. pneumophila ortholog of LapG remains unknown, we evaluated 
LapG’s catalytic activity by using P. fluorescens LapA as a model. LapA is a secreted, 
large adhesin protein. Previous experiments established that shorter constructs 
including the LapG cleavage site, a conserved TAAG motif, are processed efficiently 
by P. fluorescens LapG in vitro (30). The model substrate we use here comprises a 
235-residue-long, N-terminal fragment of LapA with a His6 tag at its C-terminus 
(LapA
Nterm
) (Fig. 3.12). Proteolysis of LapA
Nterm
 by purified P. fluorescens LapG 
produces a fragment of 15 kDa that can be detected by Western blotting with primary 
antibodies that recognize the His6 tag. D
134
A mutation in P. fluorescens LapG, which 
corresponds to the calcium-binding mutation D
136
A in L. pneumophila LapG, 
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abolishes catalytic activity completely, corroborating a calcium-dependent mechanism 
for LapG function. 
 
 
Figure 3.11: Oligomerization of LapG.  
(A) Crystallographic dimer: Analysis of crystal packing interactions reveals a putative 
LapG dimer that forms via partially hydrophobic interactions between protomers.  
(B) Oligomeric state in solution: SEC-MALS was used to determine the absolute 
molecular mass of LapG in solution. The effect of calcium on LapG’s oligomeric state 
was assessed by adding calcium to the purified protein and by additionally adding 
calcium to the chromatography mobile phase. The averaged molecular masses were 
25.1±0.3 kDa for apo-LapG, 25.7±0.3 kDa for LapG+Ca
2+
, and 22.5±0.2 kDa for  
LapG with calcium in the mobile phase.
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Similarly, L. pneumophila LapG successfully processed LapA
Nterm
, albeit less 
efficiently than P. fluorescens LapG. In these assays, we used 100-, 250-, or 375-fold 
more LapG than in the samples incubated with the P. fluorescens protease. While we 
were able to detect a cleavage product with a molecular mass similar to that produced 
by P. fluorescens LapG, indicating that the same cleavage site was recognized, 
reaction mixtures containing L. pneumophila LapG still contained uncleaved substrate. 
In addition, we observed a second, minor cleavage product with a slightly higher 
molecular mass at the two highest protease concentrations, which may indicate an 
aspecific activity under these conditions and with this model substrate. However, 
proteolysis efficiency was LapG concentration dependent. Furthermore, the calcium-
binding single-point mutations (D
136
A, E
138
A, and D
139
A in L. pneumophila LapG) 
produced markedly reduced catalytic activity. Consistently, both protease orthologs 
failed to cleave LapA
Nterm
 when incubated with EGTA, indicating that calcium is 
essential for LapG’s function as a periplasmic protease. 
Altogether, we validated our prediction of the existing LapD-LapG system 
in L. pneumophila. More importantly, we showed that it utilizes an output and 
proteolytic mechanism similar to that of its P. fluorescens counterparts.
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Figure 3.12: Proteolytic activity of L. pneumophila LapG.  
(A) A model substrate based on P. fluorescens LapA: Previous studies of P. 
fluorescens identified the LapG-cleavage site of LapA within the first 235 residues of 
the adhesin. A minimal, His6-tagged construct containing this region (LapA
Nterm
) was 
proteolyzed specifically and efficiently by P. fluorescens LapG.  
(B) L. pneumophila LapG activity: Site-specific cleavage of purified LapA
Nterm
 was 
monitored by using SDS-PAGE, followed by Western blotting with pentahistidine-
specific antibodies. L. pneumophila LapG with the E
138
A or D
139
A mutation was used 
only at the highest concentration. P. fluorescens LapG and a corresponding calcium-
binding mutant were included as positive and negative controls, respectively.  
Sensitivity to EGTA treatment was also assessed. wt, wild type.
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3.4. Discussion 
The superfamily of DUF920 domain-containing proteins or BTLCPs consists 
of more than 400 members and is conserved across the bacterial domain (13), yet 
functional and structural information has been scarce. We recently identified LapG as 
a functional example of this family, assigning it a biological role as a calcium-
dependent, periplasmic protease that is involved in biofilm dispersal of P. fluorescens 
(4, 30). Since we were unable to obtain crystals of P. fluorescens LapG thus far, we 
instead determined the high-resolution crystal structure of the LapG ortholog from L. 
pneumophila in its apo and calcium-bound states. Considering the sequence 
conservation in functionally important motifs, the structures yield prototypic models of 
LapG-like proteins and the wider family of BTLCPs. In addition, the structures 
confirmed their structural relationship to eukaryotic transglutaminases. In analogy to 
transglutaminases, LapG also shows calcium dependence, yet the exact molecular 
mechanism remains elusive in both cases despite the available structural data. 
Calcium has been known to play myriad roles in modulating protein stability 
and function. In order for a protein to interact with calcium, mainly through 
electrostatic forces, it usually has negative charges on its surface. In the case of LapG, 
the N-terminal lobe displays residues D
136
, E
138
, and D
139
, creating a highly negative 
surface potential with which Ca
2+
 can coordinate. It is possible that calcium binding to 
LapG aids in catalysis by providing increased access to the substrate or by altering 
enzyme structure or dynamics. While three of the four calcium-coordinating residues 
are strictly conserved, the fourth residue (D
120
) appears more variable. On the other 
hand, this residue is located in a flexible loop that often harbors other, more conserved 
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aspartate or glutamate residues in close proximity (Fig. 3.7), which may have a 
redundant calcium-coordinating function. It is possible that crystallographic packing 
biases the use of one position over another. The use of alternative aspartate or 
glutamate residues would likely impact the conformation of the loop, which could 
potentially alter the active or substrate-binding site. A similar mechanism has been 
discussed for mammalian tissue transglutaminases (26). 
Another effect of calcium binding on enzyme catalysis could simply be a 
change in electrostatic potential close to the active site. Calcium binding is also known 
to influence the specific subcellular localization of proteins. For example, in the case 
of calpain, calcium is required for the association of the protein with cellular 
membranes (7). In the case here, calcium binding may preferentially place LapG in 
close proximity to its substrate, LapA, which is anchored in the outer membrane. 
The identity of the physiological target of L. pneumophila LapG is unknown. 
While the structural similarity of LapG to transglutaminases may indicate different 
catalytic functions, no transamidase activity was detected in an in vitro assay (D.C. 
and H.S., unpublished data). However, L. pneumophila LapG can cleave LapA
Nterm
 
and thus is likely to function as a periplasmic cysteine protease. The reduced activity 
of L. pneumophila LapG for LapA
Nterm
 compared to that of the P. fluorescens enzyme 
could have several causes. Although we previously determined a consensus site for 
proteolytic cleavage of LapA by LapG, we also noticed that a minimal peptide 
containing that motif evades processing by the enzyme, suggesting that substrate 
recognition requires other parts of LapA (Peter D. Newell and G.A.O., unpublished 
data). Furthermore, L. pneumophila has a more complex life-style since unlike P. 
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fluorescens, it can grow autonomously or within host cells, increasing the potential 
target pool vastly. The notion that a putative target may be encoded outside the LapG-
containing operon is supported by the presence of an incomplete type I secretion 
system at this L. pneumophila locus. Furthermore, the secretion system may be 
complemented by subunits encoded outside the lapDG-containing operon. Intracellular 
growth and exposure to different environments (e.g., a different pH or temperature) 
may also have an impact on the optimal point at which L. pneumophila LapG is active. 
Altogether, these observations hamper the identification of potential L. pneumophila 
substrates by using bioinformatics. 
Yet, an interesting speculation is the possibility that LapG or related proteases 
could degrade host proteins or have a role not only in their own biofilm formation but 
also in those formed by competing bacteria. Substrate topology and protease access 
may determine the feasibility of such a model. At least in P. fluorescens, LapG 
localization to the periplasm is crucial for its regulatory effect on biofilm formation, as 
externally added protease does not appear to alter biofilm phenotypes (C.D.B. and 
G.A.O., unpublished data). 
Recently, a LapADG-like system was identified in S. oneidensis (37). In this 
system, a large outer membrane protein, BpfA, is crucial for surface attachment and 
subsequent biofilm formation. The gene that encodes BpfA is located in a seven-gene 
operon which also encodes a type I secretion system, a GGDEF-EAL domain-
containing protein similar to LapD, and a hypothetical conserved BTLCP-like protein 
homologous to LapG. An interesting finding pertains to a positive effect of calcium on 
S. oneidensis biofilm formation, which is BpfA dependent. Considering the presence 
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of putative calcium-binding sites in LapA and BpfA, these large adhesin proteins 
could function as sinks for calcium ions that, in turn, are required for proteolytic 
processing via LapG-like proteases. Such a mechanism is supported by the observation 
that bacteria have the ability to concentrate calcium in their periplasm to levels that are 
comparable to or above the measured affinity of LapG for calcium (22). Although the 
exact mechanism by which these proteins interact and function has yet to be 
established, it is quite possible that they are regulated in a fashion very similar to that 
of the Lap system in P. fluorescens (4, 29, 30). 
Although the corresponding regulators and mechanism remain elusive for the 
orthologous system in L. pneumophila, a growth phenotype in macrophages has been 
observed upon the overexpression of CdgS9, the LapD ortholog in L. pneumophila, 
indicating that the system is operational in this opportunistic pathogen (25). In 
particular, cells showed a moderate or severe growth reduction in rich broth or in 
macrophages, respectively. Our structural and mechanistic studies described here may 
facilitate future research to uncover the physiological role of this system in L. 
pneumophila and other bacteria. The protease and its interaction with the receptor 
LapD/CdgS9 also provide an attractive angle for the development of specific 
inhibitors.
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CHAPTER 4 
 
A model for the allosteric regulation of periplasmic proteolysis by c-di-GMP 
 
4.1. Abstract 
Biofilm formation, the switch between a free-swimming to a sessile life-style, 
is a prevalent adaptational strategy of many bacteria and other microbes as a response 
to changing environments. In P. fluorescens, one of the early pivotal steps, stable 
adhesion of bacterial cells to a surface, is controlled by the Lap operon. At its center, 
the transmembrane protein LapD undergoes a conformational change upon binding to 
the second messenger c-di-GMP in the cytosol, which is propagated through a HAMP 
domain to the periplasmic domain. This switch renders LapD competent to bind to a 
periplasmic protease, LapG, which in turn results in the stabilization of LapG’s 
substrate, the large adhesion protein LapA, at the cell surface. The net result of the 
inside-out signaling event is an increase in biofilm formation. While previous work 
has revealed regulatory steps, the basic structure of several functional units of the 
signaling system, and the orthologous LapD-LapG pairs in several other bacteria, the 
mechanism of switching and LapG recruitment was poorly understood. Here, we 
report the structure of a complex consisting of the periplasmic output domain of a 
LapD ortholog bound to LapG. A comparison with the corresponding output domain 
in its apo-state yields a comprehensive insight into a conserved mechanism for the  
allosteric regulation of periplasmic proteolysis.
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4.2. Introduction 
Biofilms are complex agglomerations of sessile, microbial cells encased in a 
self-secreted extracellular matrix composed primarily of exopolysaccharides, proteins 
and nucleic acids (1). They are prevalent in natural as well as industrial and hospital 
settings, and can form on a wide range of biotic and abiotic surfaces (1). Biofilm 
dwelling pathogenic bacteria have been associated with numerous persistent, 
nosocomial infections in humans such as infection of the ear or urinary tract or in 
patients suffering from cystic fibriosis (2). Since bacteria in biofilms can withstand 
antibiotic treatment, it has rendered many clinically relevant antibiotics ineffective in 
the treatment of biofilm related bacterial infections (3). This is a matter of concern 
especially in the context of increasing number of multi-drug resistant strains and a 
rather slow rate of discovery of new antimicrobial agents (4). Hence it becomes crucial 
to understand the molecular basis of biofilm formation, maintenance and dispersal in 
order to identify novel targets that could potentially be used for disrupting these 
bacterial aggregates. 
The decision to transition between a planktonic and a biofilm lifestyle is 
orchestrated by the dinucleotide based bacterial second messenger c-di-GMP, which 
modulates many different aspects of bacterial physiology (5). Higher cytosolic levels 
of c-di-GMP are often associated with stable surface attachment and biofilm 
formation, concomitant with a down-regulation in the expression of genes associated 
with motility and acute virulence. C-di-GMP is synthesized from two molecules of 
GTP by proteins with a GGDEF domain, and hydrolyzed by proteins with either an 
EAL or a HD-GYP domain (6, 7). Over the last decade or so, these c-di-GMP turnover 
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enzymes have been well characterized both structurally and functionally (6, 8-10). 
However, the receptors for c-di-GMP, effector molecules that translate the second 
messenger signal into physiological responses, are a much more diverse group and are 
slowly but steadily beginning to emerge. C-di-GMP functions as an allosteric 
modulator of these effector proteins, producing a change in their conformation upon 
binding and thus transmitting the signal to the target components mainly via 
macromolecular interactions. Some examples are proteins with PilZ domains, 
transcription factors like VpsT in Vibrio cholerae and FleQ in Pseudomonas 
aeruginosa, riboswitch aptamers of V. Cholerae, the cAMP-binding domain in Clp of 
Xanthomonas campestris (11-15). Another group of c-di-GMP receptors are proteins 
with degenerate GGDEF and/or EAL domains that lost their ability to produce or 
degrade c-di-GMP, respectively, but retained the ability to bind the second messenger 
(16, 17). 
The transmembrane protein LapD of Pseudomonas fluorescens belongs to the 
last category. It is a modular protein with tandem, enzymatically degenerate GGDEF 
and EAL domains, a HAMP domain and a periplasmic output domain (17). The output 
and HAMP domains are separated by a transmembrane domain, which spans the inner 
bacterial membrane. LapD regulates the localization and maintenance of a large 
adhesin protein LapA on the bacterial cell surface, in response to changing pools of c-
di-GMP in the cytosol, which in turn is modulated by exogenous inorganic phosphate 
levels (17-19). The periplasmic output mechanism involves a protease, LapG, which is 
encoded in the same operon as LapD and LapA. LapG is a member of the super family 
of bacterial transglutaminase like cysteine proteases (BTLCPs) and proteolyzes the 
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amino terminus of LapA in the presence of calcium, causing LapA release from the 
cell surface, thereby leading to biofilm dispersal (20, 21). Previous studies have shown 
that LapD switches between two conformations: It resides in an autoinhibited state at 
low cellular c-di-GMP levels (the ‘off’ state), and in an active state when bound to c-
di-GMP (the ‘on’ state) (19). In particular, the dinucleotide binds specifically to the 
EAL domain of LapD, which releases autoinhibitory interactions and triggers a 
conformational change in the HAMP domain concomitant with changes in its 
periplasmic domain (19). The activity states correspond to conformations that differ in 
their ability to bind to the protease LapG. In the ‘off’ state, LapD has a low affinity for 
LapG, enabling the protease to reach its substrate, LapA, which is localized at the 
outer membrane and is released into the supernatant as a result of the proteolytic event. 
In the ‘off’ state, LapG gets recruited to LapD, sequestering it away from the substrate, 
resulting in a stabilization of LapA at the cell surface. As a consequence, cells adhere 
to substrates more stably via the LapA adhesin (18, 19). 
Our previous structural characterizations identified hallmarks of the functional 
states of LapD’s cytosolic domains. We also determined the first structure of the 
periplasmic output domain of LapD, which facilitated the identification of a key 
residue in LapD critical for LapG binding and aided the identification of orthologous 
systems in several other bacteria (19). Structure-function studies on the Legionella 
pneumophila LapG provided the first atomic models for a bacterial protease of the 
DUF920 family and revealed a conserved calcium binding site critical for LapG 
activity (20). Although the endogenous target of L. pneumophila LapG remains 
elusive, the protease was able to process LapA
Nterm
, a minimal fragment of P. 
 138 
 
fluorescens LapA that serves as a model substrate, thereby proving that the basic 
mechanism of catalysis and substrate recognition remains conserved across the 
different bacterial species (20). Yet the switching mechanism of LapD’s periplasmic 
domain remained elusive, complicated by the fact of an unusual domain-swap 
observed in the LapD output domain structure. 
Here we present the crystal structures of the isolated output domain of CdgS9 
(CdgS9
output
) from L. pneumophila and that of a complex between P. fluorescens LapG 
and L. pneumophila CdgS9
output
. Besides further proving the conservation of the LapD-
LapG interaction, these structures elucidate the mode of LapG recognition by LapD 
and the basic mechanism by which LapD output is controlled. The structural analysis 
further reveals structural features controlling LapG activity and suggests anti-
cooperativity as a way of fine-tuning the LapD signaling output. 
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Figure 4.1: The LapAGD signaling system.  
(A) Model of LapD-mediated regulation of biofilm formation in P. fluorescens in 
response to exogenous Pi availability: Inner-membrane localized LapD senses 
cytosolic c-di-GMP levels and thereby modulates cell-surface associated large adhesin 
protein LapA by differential recruitment of the periplasmic protease LapG.  
(B) Genetic map of the LapDG ortholog-containing operon in L. pneumophila.  
(C) Genetic map of the Lap operon in P. fluorescens.
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4.3. Results 
Crystal structure of L. pneumophila CdgS9
output
 
We previously reported the structure of the periplasmic domain of P. 
fluorescens LapD (LapD
output
), which allowed us to identify a main residue (W
125
) that 
is required for LapG binding and signaling output (19). While the overall structure 
resembled a dimer of PAS domain folds, we were intrigued by the extensively domain 
swapped conformation it adopts in the crystals. The unusual structure prevented us 
from inferring a switching mechanism of LapD that would result in the discrete LapG 
binding states that were apparent in the biochemical data, namely that LapD would 
only bind to LapG in the periplasm when bound to c-di-GMP. In order to assess 
whether this structural feature is physiologically relevant and conserved among the 
other orthologs of this protein, we determined the crystal structure of the 
corresponding output domain of the L. pneumophila LapD ortholog, CdgS9 (residues 
22-152; space group P6122; 1 molecule/asymmetric unit; 2.1 Å resolution) (Fig. 4.2A; 
Table 4.1). The structure was solved by single-wavelength anomalous dispersion 
(SAD) phasing on crystals grown with selenomethionine-derivatized protein. Despite 
moderate sequence identity and similarity with P. fluorescens LapD
output
, the tertiary 
structure of the protein remains highly conserved. Yet, in contrast to the domain-
swapped conformation observed for P. fluorescens LapD
output
, we observed a canonical 
PAS domain fold in the case of the L. pneumophila ortholog, which comprises the 
molecule in the asymmetric unit (Fig. 4.2A). Considering crystal symmetry mates, we 
identified a dimeric state as the putative biologically relevant unit (calculated ΔGint = -
20.2 kcal/mol; total buried surface area of 3020 Å
2
) (22), with the dimer interface 
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running along a two-fold symmetry axis. The only crossover point between output 
domain protomers is observed at the termini of the protein chains, which would tether 
to the transmembrane domains in the full-length protein. Overall, the dimeric model is 
in topological agreement with this model. 
This dimer adopts a ‘closed’ conformation as opposed to the open, V-shaped 
form that we observed in case of P. fluorescens LapD
output
. As a consequence, the 
tryptophan residues (W
125
 in P. fluorescens; W
126
 in L. pneumophila) that form the 
distal tip of the PAS fold and are a main anchor point for LapG binding (19) are 
farther apart in the P. fluorescens structure than in the one of the L. pneumophila LapD 
orthologs (50 Å versus 35 Å). The dimer interface is moderately conserved 
considering the sequences of 19 putative LapD orthologs (Fig. 4.2B), and is stabilized 
by hydrophobic as well as polar interactions. A detailed description of the interface 
will follow the description of CdgS9
output
-LapG complex crystal structure (see below). 
Owing to the differences between the quaternary structures of the output domains of P. 
fluorescens LapD and L. pneumophila CdgS9, it remains to be seen if the ‘open’ and 
‘closed’ conformations of the output domain might represent different LapG binding 
states or ortholog-specific variations. 
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Table 4.1: X-ray data collection and refinement statistics. 
 
Lpg CdgS9-Pfl 
LapG 
Lpg CdgS9-Pfl LapG Lpg CdgS9
output
 Lpg CdgS9
dual
 
 (selenomethionine) (native) (selenomethionine) (selenomethionine) 
Data Collection 
X-ray source CHESS, A1 CHESS, A1 CHESS, A1 CHESS, A1 
Wavelength (Å) 0.9771 0.9771 0.9771 0.9771 
Space group P21 P21 P6122 P212121 
Unit cell     
a, b, c  (Å) 59.1, 74.7, 62.9 75.9, 73.7, 88.2 61.6, 61.6, 147.5 49.0, 135.4, 171.4 
α, β, γ (°) 90, 101.8, 90 90, 92.9, 90 90, 90, 120 90, 90, 90 
Resolution (Å)
a 
50-2.3 (2.36-2.28) 50-2.1 (2.18-2.10) 50-2.1 (2.22-2.14) 50-2.2 (2.32-2.24) 
No. of reflections     
Total 164,096 (12,523) 238,369 (16,845) 214,519 (17,521) 725,165 (40,104) 
Unique 22,898 (2,319) 55,798 (5,264) 9,799 (942) 55,207 (5,013) 
Completeness (%) 94.1 (95.6) 98.3 (93.7) 99.9 (100.0) 98.8 (91.2) 
Redundancy 7.2 (5.4) 26.1 (25.4) 21.9 (18.6) 13.1 (8.0) 
I/σ(I) 20.1 (2.3) 15.7 (2.5) 35.5 (10.1) 21.3 (2.6) 
Rmeas (%) 8.9 (67.1) 8.2 (38.7) 7.7 (30.9) 10.3 (53.2) 
Refinement
(b)
 
Rwork / Rfree (%) 
22.4 / 26.5 16.6 / 22.0 21.1 / 24.0 18.0 / 21.9 
rms deviations 
    
Bond length (Å) 
0.009 0.008 0.008 0.022 
Bond angles (°) 
1.255 1.137 1.210 1.410 
(a) Values in brackets are for the highest resolution bin. (b) Work-in-progress. 
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Figure 4.2: Structural comparison of periplasmic output domain from P. 
fluorescens LapD and L. pneumophila CdgS9  
(A) Two orthogonal views of each output domain structure are shown in ribbon 
representation, with the two protomers colored pink and gray, respectively. P. 
fluorescens LapD
output
 has an open, V-shaped conformation and is extensively domain 
swapped (19), while L. pneumophila CdgS9
output
 adopts a closed conformation with the 
arms of each protomer held parallel. Distances between the tryptophan residues in the 
conserved GWxQ motif of each protomer are indicated. The relative position of the 
inner cell membrane (gray bar) and connection to the flanking transmembrane (TM) 
helices are indicated.  
(B) The sequences of 19 orthologs of LapD were aligned and the sequence 
conservation was mapped on to the accessible surface. The surface is colored 
according to the degree of conservation of accessible residues. 
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Crystal structure of the CdgS9
output–LapG complex 
We obtained clarity in this regard for the case of CgdS9 by determining the 
structure of CdgS9
output
 in complex with LapG. In spite of our best efforts, we have so 
far been unable to either express or crystallize either of the homogeneous complexes.  
Since we had observed in the past that P. fluorescens LapG could bind L. pneumophila 
CdgS9
output
 in vitro, we went ahead and determined the crystal structure of the 
heterologous complex containing L. pneumophila CdgS9
output
 bound to P. fluorescens 
LapG by SAD phasing (space group P21; 2.1 Å resolution) (Table 4.1; Fig. 4.3A). The 
final model contained two virtually identical complexes per asymmetric unit, with 
each complex consisting of two CdgS9
output
 domains and one LapG molecule. Based 
on this structure, we were not only able to visualize the interaction interface between 
the output domain of CdgS9 (the LapD ortholog) and LapG as well as the first atomic 
model of P. fluorescens LapG, but it also revealed an active state of a LapD ortholog. 
In comparison with the previously determined apo-CdgS9
output
 structure, a model for 
the allosteric regulation of periplasmic PAS domains and the control of periplasmic 
proteolysis via LapG could be deduced. Each of the individual discoveries will be 
discussed in the following sections. 
 
The output domain-LapG interface 
Similar to the structure of apo-CdgS9
output
, the output domain in the complex 
also forms dimers, using the same interface and overall topology (differences between 
the interfaces will be discuss in detail in a later section; see below). Likewise, P. 
fluorescens LapG adopts a bilobal fold with an alpha-helical N-terminal lobe and a C-
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terminal lobe consisting of beta-sheets, which is by and large comparable to the 
structure of the L. pneumophila ortholog determined previously (minor mechanistic 
differences will be discussed below) (20). 
The complex between CdgS9
output
 (residues 22-152) and LapG (residues 50-
251) is asymmetric with a stoichiometry of 2:1, i.e. a CdgS9
output
 dimer interacts with a 
LapG monomer in the crystal lattice. The interfacial surface area buried between the 
two proteins in the complex is rather expansive (6560 Å
2
 with a calculated ΔiG = -52.3 
kcal/mol) (22). In the crystal structure of the complex, β4 in the C-terminal lobe of 
LapG is buttressed against the CdgS9
output
 dimer interface, in particular between the β-
hairpin loop that presents the conserved GW
126
xQ motif of one output domain 
protomer and α2 in chain B of the other protomer. The highly conserved tryptophan 
residue in CdgS9
output 
(W
126
), which was previously shown to be integral for LapG 
binding in the P. fluorescens ortholog, fits snugly into a predominantly hydrophobic 
binding pocket at the bottom of LapG’s C-lobe. There are several accessory hydrogen 
bond involving both side chain as well as backbone atoms and spanning a large 
surface LapG and CdgS9
output
 (Fig. 4.3B). Also, while sequence conservation on the 
LapG-interacting surface of CdgS9
output
 is moderate but apparent, the concentration of 
conserved residues on the corresponding interfacial area on LapG suggests that this 
interface is relevant for the 20 orthologous systems used to generate the sequence 
alignment, which formed the basis for this analysis (Fig. 4.3C). Although the surface 
on the LapD ortholog appears less conserved, a pronounced shape complementarity 
between the interacting surfaces may contribute to the stable recruitment of LapG to  
the periplasmic output domain of LapD orthologs.
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Figure 4.3: Crystal structure of P. fluorescens LapG and L. pneumophila 
CdgS9
output
 complex.  
(A) The LapG-CdgS9
output 
complex is shown as a ribbon representation, with the two 
protomer chains of CdgS9
output
 colored in pink and gray, while the N-and C- terminal 
lobes of LapG are shown in slate and cyan respectively. The conserved catalytic triad 
(cysteine-histidine-aspartate; C-H-D) is shown as sticks with the carbon atoms in 
orange. The highly conserved tryptophan residue (W
126
) in each protomer of 
CdgS9
output
 is presented as sticks and calcium ions are shown as spheres in green. The 
relative position of the inner cell membrane (gray bar) is indicated. Two orthogonal 
views are shown.  
(B) Surface representation of the interaction interface between CdgS9
output
 and LapG: 
The interfaces between LapG and the CdgS9 half-sides (pink and black) as well as a 
groove presented at the CdgS9
output
 dimer interface (purple) were mapped onto the 
accessible surface area of the individual proteins (left panel). The binding pocket for 
CdgS9 W
126
 in LapG is shown as a close-up view (right panel).  
(C) Surface conservation of CsgS9
output
 and LapG interaction interface: Based on the 
alignment of 19 sequences of LapD and LapG orthologs, the sequence conservation 
was mapped on to the accessible surface of each protein. The surface is colored 
according to the degree of conservation of accessible residues. For LapG, two views,  
separated by a 180° rotation, are shown.  
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P. fluorescens LapG vs. L. pneumophila LapG 
In order to ascertain the degree of conservation of the LapG orthologs and to 
detect any potential conformational changes that may occur upon binding to a LapD 
ortholog, the crystal structure of Ca
2+
-bound L. pneumophila LapG was superimposed 
onto that of P. fluorescens LapG from the complex structure (Fig. 4.4). Despite 
moderate sequence conservation between the two orthologs, the two structures are 
very similar with regard to the overall fold (Cα rmsd of 1.09Å over 136 atoms). 
However, there are a few significant differences between the two. Based on the crystal 
structure of P. fluorescens LapG in the complex, we were able to identify a rare di-
Ca
2+
 binding motif in the N-terminal lobe of LapG. This was rather unusual because 
two positively charged species when placed in such close proximity are expected to 
repel each other. In P. fluorescens LapG however, the two Ca
2+ 
ions are enclosed in a 
tight co-ordination shell, which compensates for any repulsive forces. No additional 
Ca
2+
 was added during purification or crystallization, indicating that both Ca
2+
 ions co-
purified with the complex. In contrast, we identified only a single Ca
2+
 ion at the same 
site in the L. pneumophila LapG structure, which was in agreement with binding 
studies using this ortholog. This apparent difference may be explained by the 
reorganization of a region in LapG we termed Ca
2+
-loop. In P. fluorescens LapG, an 
additional negatively charged residue (D
111
) coordinates to the Ca
2+ 
ion that is 
observed in both structures, thus allowing D
119
 to adopt an alternate side chain 
orientation and thereby accommodating the second Ca
2+ 
ion. At this point it remains 
unclear as to whether this type of di-Ca
2+
 binding is specific to P. fluorescens LapG or 
it is associated with CdgS9
output
-LapG complex formation. Alternatively, the second 
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Ca
2+
 binding site in L. pneumophila LapG could be cryptic, requiring a particular 
chemical environment to enable its occupation by divalent cations. This notion is 
supported by the overall sequence conservation of residues that coordinate both Ca
2+
  
ions in P. fluorescens LapG.
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Figure 4.4: Structural identification of a rare di-Ca
2+
 binding motif in P. 
fluorescens LapG.  
(A) On the left, a ribbon representation of superimposed atomic models of LapG from 
L. pneumophila and P. fluorescens is shown, with the former colored gray and the 
latter slate and cyan, respectively. The catalytic triad residues (C-H-D) are shown as 
sticks with the carbon atoms colored in orange. Ca
2+ 
ions are indicated as magenta and 
pink spheres in the structures of P. fluorescens and L. pneumophila LapG, 
respectively. Differential orientations of the Ca
2+
 binding loop are indicated. In the 
middle panels, close-up views and LIGPLOT analysis of the Ca
2+
 binding loop reveal 
that D
119/120 
and E
136/138 
adopt alternate side chain rotamers in the two structures, 
explaining the ability of P. fluorescens LapG to bind two calcium ions as opposed to 
one. Due to the rearrangement of the loop in P. fluorescens LapG, a third residue D
111
 
is now placed proximally to one Ca
2+
 ion, thereby stabilizing this motif.  The central 
inset shows uninterpreted electron density that was observed only in the structure of P. 
fluorescens LapG. The density has amplitudes of |Fo| to |Fc| and is contoured at 3 σ 
prior to the inclusion of calcium at that site in the refinement. In the right-top panel, 
distance difference matrices based on Cα positions of the two structures were used to 
compare the conformations in a reference frame-independent manner. Difference 
matrices were regularized using a Z-score analysis and shaded in grey indicating the 
magnitude of conformational difference (white, no difference; grey, conformational 
difference between the two orthologs). Each entry in the matrix depicts the difference 
in distance between corresponding Cα atoms in the two structures. In the bottom panel, 
the sequence logo is shown for the LapG family of proteases, indicating conservation 
of the residues in the di-Ca
2+ 
binding. 
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The second region of conformational change between CdgS9
output
-bound P. 
fluorescens LapG and the L. pneumophila LapG ortholog apparent in the superposition 
localizes to the site of interaction with LapD orthologs (Fig. 4.5). While the overall 
binding pocket for the critical tryptophan residue in the output domain of L. 
pneumophila CdgS9 (W
126
) is preserved in apo-L. pneumophila LapG, output domain 
binding requires the peeling away of β5, a short beta blade connecting to the C-
terminal helix α6 via a flexible linker. In the complex, both β5 and the linker are 
disordered, whereas β5 and part of the linker are ordered in the apo form. 
 
Apo vs complexed CdgS9
output
 
Considering that the core LapG-binding motif, the conserved GW
126
xQ loop 
(GW
125
xQ in P. fluorescens LapD
output
), is surface exposed in the apo-CdgS9
output
 
structure and potentially available for engaging LapG, it was not clear how differential 
LapG binding would be achieved. This issue could be addressed through a structural 
comparison between apo-CdgS9
output
 and its LapG-bound state. This analysis revealed 
the conformational changes that create a high-affinity binding site on CdgS9 for LapG. 
Superposition using a single protomer chain of the structures of apo- and 
LapG-bound CdgS9
output
 as the reference revealed that the periplasmic output domain 
undergoes a piston-like conformational change concomitant with a 5 Å-sliding motion 
along the output domain dimer interface (Fig. 4.6). This concerted change creates a 
cradle for the aforementioned β4-blade of LapG, which does not exist in the apo-state 
of the output domain (Fig. 4.6A). The conformational change is realized through the 
central helices of the output domain of CdgS9 and the residues that line the interface 
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between them (Fig. 4.6B). In particular, the two helices of each PAS domain fold (H1 
and H2) come together in the dimeric output module to form a 4-helix bundle in the 
apo-state (Fig. 4.6B and C). The overall structure appears bulged, which is a 
consequence of a perpendicular stacking of four phenylalanine residues (F
33
 and F
34
) 
at the base of the output module (closer to the membrane) as well as the burying of 
two arginine residues (R
75
), contributed by each symmetry related protomer (Fig. 
4.6C). The charge on arginine residue R
75
 is partially neutralized by serine residue S
48
, 
which form hydrogen bonds with R
75
. 
Due to the conformational change in CdgS9
output
 associated with LapG binding, 
the symmetry within the output domain module is broken. The tilting of one PAS 
domain fold relative to the other in the output domain module pushes the central 
helices H1 closer together, permitted by smaller residues at the interface, a 
perpendicular-to-parallel stacking transition of one F
33
-F
34
 residue pair, and the 
removal of R
75
 from the interface. The net result is a transition from a 4-helix bundle 
with poor shape complementarity with LapG to a 2-helix bundle and an overall shape 
that is able to accommodate LapG (Fig. 4.6C). 
Taken together, the crystal structures of apo-CdgS9
output
 and a CdgS9
output
-
LapG complex yield a detailed model for the activation of LapD by c-di-GMP binding 
to its cytosolic module, which releases an autoinhibitory interaction, which like 
triggers a conformational change in the periplasmic domain through the 
juxtamembrane HAMP domain and transmembrane segments. LapG binding to the 
off-state of LapD is prevented by an apparent surface mismatch. In contrast, activated 
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LapD displays a surface that allows LapG to interact with both half-sides of the output 
domain module. 
 
Figure 4.5: Conformational changes between apo- and CdgS9
output
-bound LapG. 
(A) A close-up view of the C-terminal lobe of LapG is shown. The structure of L. 
pneumophila LapG shown in gray is overlaid on that of P.fluorescens LapG, colored 
in slate and cyan. Disordered regions not resolved in the crystal structures are shown 
as dots. Calcium ions are represented as magenta spheres. The catalytic triad residues 
(C-H-D) are shown as sticks with the carbon atoms colored in orange.  
(B) A close-up view of the interaction surface between LapG and CdgS9
output 
identifies 
a L. peumophila LapG conformation that is incompatible with CdgS9 binding. 
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Figure 4.6: Conformational changes in CdgS9
output
 between the apo-state and in 
complex with LapG.  
(A) Top and side views of the superposition of apo-CdgS9
output
 and LapG-bound 
CdgS9
output
 with chain A as the reference. Protomers A and B of apo-CdgS9
output
 are 
colored tan and yellow, while chains A and B of LapG-bound CdgS9
output 
are colored 
pink and gray, respectively. Both cartoon (left panel) and surface (right panel) 
representations of LapG are shown.  
(B) Detailed view of the conformational differences between the two output module 
states. Two perpendicular views are shown. The right panel shows slices of the top 
view.  
(C) Cartoon model of the structural transition from an apo-state to a LapG binding-
competent state of LapD orthologs based on the analysis shown in panels (A) and (B). 
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Stoichiometry and asymmetry of the LapG-CdgS9
output
 complex 
We were intrigued by the 2:1 stoichiometry of the LapG-CdgS9
output
 complex 
in the crystal structure. Since full-length LapD is considered constitutively dimeric 
(17-19) owing to its HAMP and output domains (19), and the apo-CdgS9
output
 structure 
is symmetric, we wondered if the formation of a symmetric, 2:2 complex was 
theoretically possible. Inspection of the complex structure revealed an asymmetric 
structure in which the conformational changes were not equivalent in the two half-sites 
of the output domain dimer (Fig. 4.6C). Furthermore, superimposing a CdgS9
output
 
domain that engages LapG via its GW
126
xQ loop onto the output domain of the 
complex structure, which is not bound to LapG, reveals poor shape complementarity at 
the putative second LapG binding site (Fig. 4.7A). While this could be due to a 
substoichiometric co-expression of the complex components or an incomplete 
transition of the output domain to a fully active, symmetric state, it may also indicate 
mechanisms that would favor an asymmetric 2:1 complex. 
While we cannot distinguish between these possibilities based on our current 
data, we can assess the stoichiometry of the complex in solution. We used size-
exclusion chromatography-coupled multi-angle light scattering (SEC-MALS), a 
method that yields the absolute molecular weight of a protein or complex as well as its 
polydispersity index, as it is eluted from a gel filtration column (Fig. 4.7B). First, we 
analyzed the complexes obtained from co-expression of LapG and LapD
output
 
orthologs. The [P. fluorescens LapG - L. pneumophila CdgS9
output
] complex sample 
used for crystallization eluates predominantly as a 2:1 complex although a slight 
upwards trend at the left tail-end of the peak may hint at a fraction of higher-order or 
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2:2 complexes. Next we used the complex between homologous proteins (CdgS9
output
 
and LapG) from L. pneumophila. The L. pneumophila complex obtained through co-
expression also purifies predominant 2:1 species. While this observation ruled out any 
discrepancies that may arise from studying a heterologous complex, it did not answer 
whether a 2:2 complex can be achieved. To ascertain this possibility, we spiked the co-
expressed and purified complex with an excess purified L. pneumophila LapG. If 
anything, the size distribution of the complexes got even tighter, with only a 2:1 
species being observed. 
Together, these results indicate the existence of mechanisms that prevent the 
formation of symmetric 2:2 complexes between LapG and LapD, which are apparent 
from the structural characterization. Preliminary data using the full-length receptor 
even suggest anti-cooperativity as a mode for fine-tuning complex formation (data not 
shown). 
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Figure 4.7: Stoichiometry of CdgS9
output
-LapG complex.  
(A) Superimposition of a CdgS9
output
 domain that engages LapG via its GW
126
xQ loop 
onto the output domain of the complex structure, which is not bound to LapG, reveals 
poor shape complementarity at the putative second LapG binding site. 
(B) Stoichiometry of CdgS9
output
-LapG complex in solution. CdgS9
output
-P. fluorescens 
LapG elutes as a 2:1 complex with a slight tendency to form a higher ordered species. 
CdgS9
output
-L. pneumophila LapG is predominantly a 2:1 stoichiometric species and is  
not responsive to excess L. pneumophila lapG.
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4.4. Discussion 
The structural analyses described above of the output domain of the L. 
pneumophila CdgS9 ortholog in its apo-state and when bound to a LapG ortholog 
revealed the molecular mechanism by which LapD regulates proteolysis in the 
periplasm by sequestering the protease LapG. As an extension, we predict that the 
structural transitions observed in the isolated output domain are triggered by an 
allosteric mechanism involving the cytoplasmic domains of LapD in the context of the 
full-length, transmembrane protein. As such, we argue that the isolated domain is in a 
deregulated state and is able to react to LapG binding since regulatory, autoinhibitory 
domains are lacking, that would lock the receptor in its off-state (the apo state). This is 
consistent with the observation that the isolated output domain is a poor competitor for 
the interaction between LapG and full-length LapD (data not shown). Nevertheless, 
the conservation of the involved interfaces and motifs in the otherwise fairly divergent 
LapD family of receptors suggest that the proposed mechanism is more generally 
applicable. Validation of the working model by using homology modeling and 
structure-guided site-directed mutagenesis in P. fluorescens is currently under way. 
Also, while we currently favor the possibility that the domain-swapped P. fluorescens 
LapD
output
 structure (Fig. 4.2A) is an artifact, we are in the process of formally 
assessing the quaternary structure arrangement. 
LapD was initially discovered in P. fluorescens as a crucial regulator of cell 
adhesion, and the underlying regulatory network remains one of best-understood 
signaling systems with regard to LapD receptor function but also considering other c-
di-GMP-dependent pathways (17-21). LapD-like signaling nodes were validated in a 
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few other biofilm-forming bacteria. Unfortunately, while we have strong evidence that 
they are regulated in a similar fashion, we know very little about the biological 
function of other orthologs, especially when it comes to pathogens. Here, we used the 
L. pneumophila LapD ortholog, CdgS9, which facilitated the structural studies. 
Although genetic knock-outs have no obvious phenotype in L. pneumophila, 
overexpression of CdgS9 has an effect on intracellular growth of the pathogen (48). 
Future studies will have to address the physiological pathways that LapD and LapG 
orthologs regulate. Until then, these proteins remain orphan c-di-GMP receptors and 
proteases, respectively. 
Previous studies on the switching of HAMP domains and periplasmic domains 
in bacterial proteins have yielded several models for the conformational changes 
associated with changes in activity state of these proteins. The proposed structural 
rearrangements range from piston motions to scissor-type motions (29, 30). Here we 
describe the conformational changes associated with the transition of a ligand-free 
LapD receptor output domain to a LapG-bound state. The overall motion has 
components of a piston-type model, where one half-sides shift vertically along the 
second half-side of the dimeric output domain module, and a scissor-like model 
encompassing a sliding motion along the dimer interface. Considering the current 
model for HAMP domain-switching which involves undergoing small amplitude 
translations or rotations during signal transduction (29, 30), we predict that the output 
domain follows the conformational changes in the HAMP as a direct response. At the 
same time, the apparent asymmetry of the complex suggests mechanisms inherent to 
the output domain that counteract an activating signal and ultimate contribute to a anti-
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cooperativity. The current working model predicts that (transient) occupation of the 
second LapG binding site on the dimeric output domain of LapD would release LapG 
at the first, high-affinity site. 
In summary, we propose a detailed model for how c-di-GMP binding to the 
cytoplasmic domain of LapD sets off a conformational change that is communicated 
through the HAMP domain to the periplasmic domain. This allosteric trigger allows 
LapD to bind to LapG in the periplasm and as a result prevents LapA cleavage. Based 
on the conservation of binding events and key sequence motifs, we predict that the 
model may be universal for LapD-like protein, which may also include receptors that 
signaling in the opposite direction (‘outside-in’) by translating environmental signals 
emerging in the periplasms into altered activity states in the cytoplasm. Future studies 
will ascertain the generality of our current model and the potential variations thereof.
164 
 
4.5. Material and Methods 
Protein expression and purification 
The periplasmic output domain of the L. pneumophila LapD ortholog CdgS9 
(lpg0829; residues 22-152) and P. fluorescens LapG lacking the signal peptide 
(Pfl01_0130; residues 50-251) were amplified from genomic DNA by standard PCR 
and cloned separately into a pET28a based vector (Novagen) that adds an N-terminal, 
cleavable His6-SUMO tag, as well as together into a bacterial dual expression vector, 
pETDuet-1 (Novagen). With regards to the duet vector, L. pneumophila His6-SUMO-
CdgS9
output
 and P. fluorescens LapG were cloned into MCS-1 and MCS-2, 
respectively. 
          Native and selenomethionine-substituted proteins were over-expressed in E. coli 
BL21 T7 Express or T7 Express Crystal cells (New England Biolabs), respectively. 
For the expression of native proteins, cultures were grown at 37°C in Terrific Broth 
(TB) media supplemented with 50 μg/ml kanamycin. At an OD600 of ~1, the 
temperature was reduced to 18°C, and protein expression was induced by adding 1 
mM IPTG. Selenomethionine-labeled proteins were expressed in cells grown at 37°C 
in M9 minimal media supplemented with the desired antibiotic, vitamins (1 μg/ml 
thiamin and 1 μg/ml biotin), carbon source (0.4% glucose), trace elements, and amino 
acids (50 μg/ml of each of the 20 amino acids with selenomethionine substituting for 
methionine). Protein expression was induced at an OD600 corresponding to ~0.6. In 
both cases, protein expression was allowed to proceed for 16 hours at 18°C, after 
which cells were harvested by centrifugation, re-suspended in Ni-NTA buffer A (25 
mM Tris-HCl [pH 8.5], 500 mM NaCl and 20 mM imidazole), and flash frozen in 
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liquid nitrogen. Cell suspensions were thawed and lysed by sonication. Cell debris was 
removed by centrifugation and the clear lysates were incubated with NiNTA resin 
(Qiagen) that was pre-equilibrated with Ni-NTA buffer A. The resin was washed with 
20 column volumes of buffer A, followed by protein elution with 5 column volumes of 
NiNTA buffer B (25 mM Tris-HCl [pH 8.5], 500 mM NaCl and 300 mM imidazole). 
The eluted proteins were buffer-exchanged into a low-salt buffer (25 mM Tris-HCl 
[pH 8.5] and 150 mM NaCl) on a fast desalting column (GE Healthcare). Proteins 
were subjected to size exclusion chromatography on a Superdex 200 column (GE 
Healthcare) pre-equilibrated with gel filtration buffer (25 mM Tris-HCl [pH 8.5] and 
150 mM NaCl). Where indicated, the His6-SUMO moiety was cleaved off by using the 
yeast protease Ulp-1 following desalting. Ulp-1, uncleaved protein and the cleaved 
fusion tags were removed by NiNTA affinity chromatography prior to the final gel 
filtration.  
For co-purification of the CdgS9
output
-LapG complex, the procedure remained 
identical barring the use of low salt buffers, i.e. instead of 500mM NaCl, Buffers A 
and B had 200 mM salt, while the final gel-filtration buffer contained 200mM NaCl. 
Purified proteins were concentrated on Amicon filters with an appropriate size cutoff 
to concentrations >30 mg/ml, flash frozen in liquid nitrogen and stored at -80°C. Site-
directed mutagenesis was carried out using the Quikchange kit (Agilent Technologies) 
following the manufacturer’s instructions, followed by validation through DNA 
sequencing. 
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Crystallization, data collection and structure solution 
Crystals were obtained by hanging drop vapor diffusion mixing equal volumes 
of protein (10-30 mg/ml) and reservoir solution followed by incubation at 20°C. For 
the native and selenemethionine-derivatized L. pneumophila CdgS9
output 
crystals, the 
reservoir solution contained 0.1M Bis-Tris (pH=5.0), 14% PEG3350 and 4% v/v 
2,2,2-Trifluoroethanol. Crystals of the native CdgS9
output
-LapG complex were obtained 
from a reservoir solution containing 0.1M Bis-Tris (pH=6.0) and 0.1M Magnesium 
Formate. Our initial efforts directed towards experimental phase determination proved 
intractable due to extremely low expression levels of the selenomethione-substituted 
CdgS9
output
-LapG complex. Hence phases were determined by harvesting crystals 
generated by in vitro mixing of P. fluorescens LapG expressed as the 
selenomethionine-derivatized protein, with native L. pneumophila CdgS9
output 
from the 
same condition as that for the native ones. For cryo-protection, crystals were soaked in 
reservoir solution supplemented with 20-25% xylitol. Cryo-preserved crystals were 
flash-frozen and stored in liquid nitrogen. Data was collected on frozen crystals at 100 
K using synchrotron radiation at the Cornell High Energy Synchrotron Source 
(CHESS, Ithaca). 
Data reduction was carried out with the software package HKL2000 (23). 
Experimental phases for the initial structure determination were obtained from Single 
Anomalous Diffraction (SAD) experiments on crystals grown from selenomethionine-
derivatized proteins by using the software package PHENIX (24). Refinement in 
PHENIX and COOT (25) yielded the final models. Data collection and refinement 
statistics are summarized in Table 4.1. Illustrations were made in Pymol 
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(Schrödinger). Alignments were generated using ClustalW2 (26). Sequence logos were 
generated using WebLogo (27, 28). 
 
Size exclusion chromatography-coupled multi-angle light scattering (SEC-MALS) 
SEC-MALS measurements were carried out by injecting purified proteins (100 
µM) onto a Phenomenex gel filtration column pre-equilibrated with gel filtration 
buffer (25 mM Tris-HCl [pH 7.4] and 100 mM NaCl). The SEC system was coupled 
to an 18-angle, static light scattering detector and a refractive index detector (DAWN 
HELEOS-II and Optilab T-rEX, respectively; Wyatt Technology). Data was collected 
at 25°C every second at a flow rate of 1 ml/min and analyzed with the software 
ASTRA, yielding the molecular weight and mass distribution (polydispersity) of the 
samples. For data quality control and normalization of the light scattering detectors,  
monomeric bovine serum albumin (Sigma) was used. 
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CHAPTER 5 
 
Conclusions 
 
Bacteria have the ability to form surface-attached communities, called 
biofilms, in both free-living environmental habitats and during pathogenic 
colonization in infectious diseases (1). Many of the cellular processes contributing to 
biofilm formation are regulated by the molecule bis-(3'-5')-cyclic dimeric guanosine 
monophosphate or or c-di-GMP. This RNA-based dinucleotide has emerged as a 
broadly conserved intracellular second messenger in bacteria, regulating adhesion, 
motility, biofilm formation, differentiation and cell cycle progression, while exerting 
control at transcriptional, translational and post-translational levels (2-7). Cyclic-di-
GMP is synthesized from two molecules of GTP by diguanylate cyclases (DGCs) 
containing the GGDEF domain (8). Degradation of c-di-GMP is accomplished by 
phosphodiesterases (PDEs) containing either an EAL (9, 10) or a HD-GYP domain 
(11). Many GGDEF and EAL domains occur in multi-domain proteins, fused with 
diverse regulatory domains common to bacterial signaling proteins (12). These 
regulatory domains can modulate synthesis or degradation of c-di-GMP in response to 
a broad range of signals such as light (13), oxygen (14), or through post-translational 
modifications such as phosphorylation (15) or proteolysis (13). Up until now, only a 
few of these environmental and cellular cues that modulate c-di-GMP mediated 
signaling pathways have been identified. In order to fully appreciate the 
multidimensional influence of these signaling networks on bacterial physiology and 
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pathogenesis, it is important that we strive to unveil novel sensory inputs and their 
mechanism of downstream signal propagation. 
In contrast to c-di-GMP turnover domains (GGDEF, EAL and HD-GYP) that 
are readily identifiable based on preliminary sequence analysis, the staggering 
diversity in modes of c-di-GMP binding has made the recognition of its effector 
components quite challenging. Yet, identification of these receptors is instrumental to 
fully gauge the entire gamut of cellular processes regulated by this this cyclic 
nucleotide. Receptors of c-di-GMP identified thus far include proteins with PilZ 
domains (17, 20, 21) or degenerate GGDEF/EAL domains, transcription factors and 
riboswitches (5, 7, 22, 43), and have been shown to impact exopolysaccharide (EPS) 
synthesis (16-18), motility (19-21), transcription (22-24), and sub-cellular (25) or cell-
surface protein localization (26). However, out of these only a few studies have 
revealed the molecular details of how these c-di-GMP effectors control their final 
outputs (22, 25-31).  
The existence of an astonishingly large number of predicted c-di-GMP 
signaling proteins in certain bacterial genomes (there are 43 and 22 in our study 
organisms, Pseudomonas fluorescens Pf0-1 and Legionella pneumophila, respectively) 
raises the possibility that c-di-GMP signaling networks are extraordinarily complex. 
Recent studies have provided strong evidence that c-di-GMP signaling proteins (DGCs 
or PDEs) can produce distinct outputs through differential subcellular localization of 
their targets (32-34). Other studies have shown that c-di-GMP signaling proteins in the 
same pathway often physically interact with one another or with their targets (35). 
These data, combined with the well-established role of oligomerization in regulating 
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DGC and PDE activities, points to direct protein-protein interactions and multi-protein 
complexes as a likely means to exert spatial and temporal compartmentalization of 
specific c-di-GMP pools. It is possible that some of these c-di-GMP signaling proteins 
may be expressed only under specific growth conditions or in response to certain 
environmental variations. For example, rapA, which encodes a c-di-GMP specific 
PDE in P. fluorescens, is expressed only under conditions of exogenous inorganic 
phosphate (Pi) starvation (36). However, it has still not been completely understood as 
to how such spatiotemporal sequestration can be achieved.  
Furthermore, the apparent imbalance between the number of c-di-GMP 
metabolizing enzymes and its sensors suggests that new classes of c-di-GMP-binding 
proteins are only waiting to be uncovered. Exciting new high-throughput methods of 
identification of potential c-di-GMP receptors have recently been proposed. One such 
method involves use of a c-di-GMP-affinity resin to capture target proteins from cell 
lysates (40), while the other relies on utilizing an E. coli based over-expression 
system, thereby circumventing the need of protein purification (41). The success of the 
proposed techniques would contribute to a better characterization and understanding of 
the complex c-di-GMP signaling network. 
Additionally, understanding how c-di-GMP receptors participate in generating 
biological outputs has also remained a poorly understood process, yet essential to 
appreciating a critical component of the bacterial lifestyle, that is, the transition 
between motile and sessile states. This is particularly important because it is estimated 
that approximately 80% of human infections involve bacterial biofilms. Since biofilm 
dwelling bacteria is much more tolerant to antibiotic treatment as compared to 
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planktonic cells, it has become extremely difficult to remove these microbial 
aggregates in clinical as well as industrial settings. Thus, in order to come up with 
effective measures to prevent and/or disrupt biofilms, we need to attain a fundamental 
understanding of the molecular mechanisms and regulatory pathways that govern this 
developmental process in bacteria. 
It has been established that c-di-GMP is necessary for biofilm formation and 
maintenance in bacteria. Hence, decreasing intracellular c-di-GMP levels should lead 
to biofilm dispersal. This indeed is true in case of P. fluorescens biofilms, where 
detachment is initiated upon upregulation in the expression of a c-di-GMP specific 
PDE RapA. In P fluorescens, stable surface attachment and commitment to a 
sedentary lifestyle in response to nutrient availability in the environment, is dependent 
on the appropriate localization of an outer-membrane embedded, large adhesin protein 
LapA (36). LapA plays a critical role in an early step in biofilm development called 
“irreversible attachment”, during which bacterial cells attach to a surface via their 
longitudinal axis (36), and its secretion requires LapEBC, an ATP-binding cassette 
type transporter (37). So how does the adhesin LapA impact biofilm development?           
It has been shown that LapD, an inner-membrane localized c-di-GMP receptor 
that binds the dinucleotide via its catalytically degenerate EAL domain, plays an 
important role in the localization and maintenance of LapA, by differential recruitment 
of a periplasmic cysteine protease LapG, in response to changing pools of c-di-GMP 
in the cytoplasm, which in turn is regulated by a system (Pst) that monitors inorganic 
phosphate levels in the environment (26, 29, 30, 36, 37). LapD is a multi-domain 
protein with a cytoplasmic HAMP-GGDEF-EAL module and a periplasmic output 
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module (26). In order to gain a molecular insight into the mechanism of LapA 
regulation by LapD, we conducted X-ray crystallographic analyses of the structure of 
the intracellular and periplasmic modules of LapD.  
Our structural analyses of LapD revealed an autoinhibited conformation of the 
cytosolic GGDEF-EAL dual domain module (LapD
dual
) in the apo-state, a dimeric 
form of c-di-GMP-bound EAL domains in the active state (LapD
EAL.
c-di-GMP), and 
an extensively interwoven, domain-swapped dimer architecture of the periplasmic 
output domain (LapD
output
) that is competent for LapG binding. The above data, 
coupled with extensive biochemical and genetic analyses, helped us formulate a 
hypothesis for the mechanism of c-di-GMP mediated LapA regulation by LapD (29, 
30, Chapter II). 
When exogenous inorganic phosphate availability is severely limited, 
intracellular c-di-GMP levels are low and LapD is held in an autoinhibited 
conformation or an “off” state, in which access of c-di-GMP to the EAL domain is 
partially blocked. In this conformation, LapD’s output domain is unable to bind LapG 
in the periplasm. Thus, LapG gains access to and cleaves the amino-terminus of LapA, 
releasing this critical biofilm adhesin from the cell surface and thereby leading to 
biofilm dispersal. In contrast, when there is abundant inorganic phosphate in the 
growth medium, c-di-GMP levels in the cytosol increases and it binds to the EAL 
domain of LapD, disrupting the autoinhibitory state and inducing a conformational 
change that is detected by the HAMP domain and relayed on to the periplasmic output 
domain causing sequestration of the periplasmic protease LapG, thereby preventing 
 176 
 
the proteolysis of LapA, and ultimately leading to LapA retention on the outer 
membrane and hence stable surface attachment.  
By revealing key motifs for the regulation of LapD, we identified similar 
signaling systems in many other bacterial strains that might control periplasmic protein 
processing events in a similar regulatory fashion (29, 30). While functionally 
important motifs and the overall domain organization were conserved, the overall 
sequence identity was rather low. Hence, we decided to establish the conservation of 
the basic receptor function and autoinhibition based on the isolated, soluble domains 
of the Lap orthologs from Legionella pneumophila, the causative agent of 
Legionnaires’ disease in humans (46). 
Our work on the LapG and LapD orthologs from L. pneumophila indeed 
established that they form a complex as part of a conserved regulatory system, with a 
significant degree of cross-specificity between the two systems. In order to shed light 
on the molecular details of LapG function, we also determined the crystal structure of 
L. pneumophila LapG in its apo- as well as Ca
2+
-bound states. This in turn provided 
the first atomic models of bacterial proteases of the DUF920 family and revealed a 
conserved calcium-binding site important for LapG function (38, 39, Chapter III). 
Although the identity of the endogenous substrate for the L. pneumophila ortholog of 
LapG remains unknown, we have shown that the enzyme can proteolyze the 
corresponding P. fluorescens substrate, indicating a common catalytic mechanism and 
substrate recognition (38). In future, it would be interesting to validate, structurally 
and functionally, the hypothesis that LapG recognizes discrete features of the N-
terminal domain of LapA that allows this protease to specifically target the adhesin. 
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Additionally, efforts are underway to identify the corresponding LapG substrates in 
the pathogenic strains. A detailed understanding of the proteolytic cleavage 
mechanism will be instrumental for exploiting this signaling system as a therapeutic 
target in the battle against infectious diseases. 
Our structural analyses of the output domain of CdgS9 (CdgS9
output
) from L. 
pneumophila and that of a complex between P. fluorescens LapG and L. pneumophila 
CdgS9
output
, has furthered our mechanistic understanding of c-di-GMP regulated 
LapD-LapG mediated signal propagation in the periplasm. Breaking this interaction 
pharmacologically might provide a route to prevent or dispel bacterial biofilms and 
possibly host-pathogen interactions, and could potentially yield a solid basis for 
structure-guided drug design (Chapter IV).   
In summary, our work has led to the identification and characterization of a 
novel yet well-conserved “inside-out” signal relay mechanism in bacteria wherein 
cytosolic levels of a nucleotide based second messenger, namely c-di-GMP, can 
regulate the localization of a cell-surface associated protein LapA (29, 30) via an 
inner-membrane anchored c-di-GMP receptor LapD. This is the first structure-function 
analysis of a complete c-di-GMP signaling module in bacteria, from the primary signal 
(environmental Pi) to the final cellular output (biofilm dispersal). Our X-ray 
crystallographic studies on the different components of this pathway has provided 
molecular snapshots of the ongoing signaling events and has steered our investigation 
towards attempts to elucidate the function of these proteins as signal broadcasters in 
the big picture of prokaryotic signaling networks.  
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Additionally, the identification of analogous signaling cascades in several other 
clinically relevant pathogenic species including L. pneumophila, V. cholerae, P. 
aeruginosa etc. implies that the results discussed here might have broader implications 
for receptors predicted to mediate either inside-out or outside-in signaling involving 
the bacterial second messenger c-di-GMP. While LapA regulation happens to be the 
ultimate output of this pathway in P. fluorescens, it is possible that orthologous 
systems in other pathogens identified through bioinformatics analysis, might involve 
regulation of secretion of hemolysin-like toxins, which are predicted to have the same 
N-terminal domain architecture as that of LapA. If so, this would indeed be a novel 
mechanism of control of microbial pathogenesis by c-di-GMP. 
While we have made tremendous progress in understanding some of the key 
regulatory and architectural features of the LapD-LapG signaling module, several 
questions still remain unanswered. In particular, while we have successfully 
characterized the autoinhibited apo-state and the active c-di-GMP-bound state of 
cytoplasmic LapD, the exact role of the HAMP domain in inside-out signal 
propagation in the context of the full-length receptor remains poorly understood. The 
HAMP domain found in LapD occurs in a large number of bacterial proteins, 
especially histidine kinases and DGC/PDEs (20). Their structure has been studied in 
isolation, yet little is known about the mechanism of signal relay by this dimeric 
protein domain. In case of P. fluorescens LapD, we have identified both the input 
signal transmitted by the HAMP domain (corformational rearrangement induced by c-
di-GMP binding), and the cellular output regulated by HAMP-mediated changes in 
protein structure (LapA processing by LapG). Furthermore, with the identification of 
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more than 300 proteins that contain this HAMP-GGDEF-EAL module, many of which 
even have intact active site sequences, it is likely that future mechanistic studies on 
LapD signaling will not only shed light on the unique inside-out signaling mechanism 
described for LapD homologs, but will also be more generally applicable to proteins 
involved in outside-in signaling where they work as environmental sensors. In this 
regard, future attempts towards crystallization of full-length LapD could potentially 
unravel the signaling mechanisms in these HAMP-containing proteins. 
It is also not clear as to how intracellular signaling specificity is achieved. 
From published and unpublished work it is clear that only a subset of DGCs and PDEs 
feed into LapD, while the others, who in spite of catalyzing the same basic enzymatic 
reaction do not alter LapD's activity. Some of this may be explained by differential 
expression, but not all of the apparent specificity can be explained by it. There is an 
emerging body of literature suggesting that direct protein-protein interactions between 
the c-di-GMP turnover enzymes and the c-di-GMP effectors (4, 42, 47), creates local 
gradients or microcompartments of the dinucleotide within the cytosol, thereby 
eliciting a specific response. Thus, understanding how multiple c-di-GMP signaling 
proteins interact with each other or remain isolated in order to generate a biological 
response is critical to unraveling the intricacies of c-di-GMP signaling in the bacterial 
kingdom. 
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